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 Abstract 1 
1. Abstract 
The process of oligodendrocyte differentiation and myelination involves biosynthesis and 
degradation of various lipids, proteins and carbohydrates. Alterations in these metabolic 
pathways can lead to neuropathological symptoms and demyelinating diseases like 
Metachromatic leukodystrophy (MLD). This study aims at addressing the roles of two 
molecules namely (a) polysialic acid (PSA), an oligosaccharide and (b) sulfatide, a 
glycosphingolipid, in the process of oligodendrocyte differentiation, myelination and in 
demyelinating disorder, MLD. 
Oligodendrocyte precursor cells express neural cell adhesion molecule (NCAM) which is 
post-translationally modified by addition of polysialic acid (PSA). As these cells undergo 
differentiation, they downregulate the synthesis of PSA. To understand whether 
downregulation of PSA is a prerequisite for oligodendrocyte differentiation and myelination, 
transgenic mice overexpressing polysialyltransferase, PST, under the control of proteolipid 
protein (PLP) promoter were generated, so that these mice do not downregulate 
polysialylation and show an increased level of PSA on NCAM-120 in mature 
oligodendrocytes.  The transgenic mice sustained PSA modification of NCAM-120 in all 
developmental stages. These mice displayed partial co-localization of PSA and myelin basic 
protein (MBP) with localization of PSA-NCAM in myelin. Sustained PSA expression resulted 
in a decrease in myelin content and MBP protein. Structural analysis of these mice showed 
normal myelination in the central nervous system (CNS) and peripheral nervous system 
(PNS), but adult mice displayed structural abnormalities like axonal degeneration and 
redundant myelin. In situ hybridization indicated a reduction in the number of differentiated 
oligodendrocytes in the forebrain with no reduction in the number of oligodendrocyte 
precursor cells. Analysis of primary oligodendrocyte cultures displayed a less differentiated 
morphology with fewer processes and membranous extensions without any changes in the 
localization of NCAM and myelin associated glycoprotein (MAG) and with no significant 
difference in the percentage of MBP positive cells.  Altogether these observations indicate 
that downregulation of PSA is essential for myelination but is not the only prerequisite for 
efficient myelin formation and that PSA is also involved in myelin maintenance and stability. 
Lipids play an important role in maintaining membrane stoichiometry as well as in the 
process of myelination. De-regulation in lipid degradation results in disorders like MLD. 
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MLD is a lysosomal sulfatide storage disorder characterized by accumulation of sulfatide in 
the nervous system and other organs. The disease is caused by deficiency in the sulfatide 
degrading enzyme arylsulfatase A (ASA). MLD patients suffer from neurological symptoms 
and progressive demyelination. ASA(-/-) mice, the only animal model of MLD, in part 
displayed some, but less severe symptoms and no demyelination like MLD patients, thus 
resembling the earlier stages of human MLD. Since sulfatide storage is critical for MLD 
disease manifestations, it was hypothesized that increased sulfatide storage in ASA(-/-) mice 
might display the neuropathological symptoms of the disease. Hence, in order to increase 
sulfatide storage in ASA(-/-) mice, transgenic/ASA(-/-) [tg/ASA(-/-)] mice overexpressing 
galactosylceramide sulfotransferase (CST) under the control of PLP promoter were generated 
and analyzed. These tg/ASA(-/-) mice displayed a significant increase in sulfatide, in both 
central and peripheral nervous system. Animals older than one year displayed severe 
neurological defects like gait disturbances, hind limb paralysis and decreased nerve 
conduction velocity. Demyelination and hypertrophic neuropathy of peripheral nerves was 
prevalent in these mice, along with demyelination of the central nervous system. Biochemical 
analysis showed a decrease in MBP. Altogether these observations indicate that, increasing 
sulfatide storage resulted in neuropathological symptoms and demyelination akin to the 
advanced stages of MLD. 
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2. Introduction 
The nervous system is composed of two major classes of cells, namely, neurons and glial 
cells. Neurons transmit action potentials through their axons and dendrites from different 
regions of the body to the brain and vice versa, whereas, glial cells are the supporting cells 
that perform a variety of functions like myelination, phagocytosis and maintenance of energy 
homeostasis. The number of glial cells far exceeds the number of neurons in the mammalian 
brain. During the development of the mammalian cortex, proliferating neuroepithelial cells 
from the ventricular and subventricular zone of the telencephalic brain give rise to neural and 
glial precursor cells (Doetsch et al., 1997). These cells in turn proliferate, migrate and 
differentiate to give rise to the complex interconnected neuroglial network. 
Glial cells are classified based on their morphology and function into astrocytes, microglia, 
ependymal cells and oligodendrocytes in the central nervous system and Schwann cells in the 
peripheral nervous system. 
2.1 Oligodendrocytes  
Oligodendrocytes are cells of the central nervous system which generate myelin membranes. 
Although oligodendrocytes in general are myelin forming cells, a class of oligodendrocytes 
called satellite oligodendrocytes, are not involved in myelin synthesis, but maintain the 
microenvironment around neurons (Ludwin, 1997). During the development of the vertebrate 
central nervous system, the neural tube gives rise to neuroepithelial cells. Oligodendrocyte 
precursor cells (OPCs) are generated during late embryogenesis and early postnatal 
development in the ventricular regions of brain and spinal cord (Yu et al., 1994; Spassky et 
al., 1998; Timsit et al., 1992). These cells then migrate (Richardson et al., 2000) extensively 
before they differentiate into myelin-forming oligodendrocytes of the white matter. During 
the process of their generation, proliferation, migration and maturation different markers are 
expressed which play a crucial role in their development. The oligodendrocyte precursors 
express several different markers like platelet derived growth factor (PDGF) α-receptor 
(Pringle and Richardson, 1993), CNPase (Richardson et al., 2000), integrin receptors (Milner 
et al., 1996) and PSA-NCAM (Wang et al., 1994). The expression of these proteins helps in 
the proliferation and migration of oligodendrocyte precursors. During this stage of 
development, the OPCs are influenced by growth factors like platelet derived growth factor 
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(PDGF) and basal fibroblast growth factor (bFGF) (Gard and Pfeiffer, 1993; Hardy and 
Reynolds, 1993). PDGF and bFGF stimulate the proliferation of OPCs by binding to PDGF α- 
receptors and FGF receptors respectively. Extra-cellular matrix proteins like Tenascin-C 
(Bartsch et al., 1994) and Tenascin-R (Pesheva et al., 1997) also play a crucial role in the 
migration of OPCs. The OPCs get converted to progenitors, which have a bipolar morphology 
and then to pre-oligodendrocytes. During this stage of their development the pre-
oligodendrocytes stop migrating and undergo morphological changes. They lose their bipolar 
morphology and develop a branched morphology. These pre-oligodendrocytes develop into 
immature oligodendrocytes. These immature oligodendrocytes undergo maturation to become 
mature non-myelinating oligodendrocytes. During this stage of maturation these cells express 
myelin basic protein (MBP), proteolipid protein (PLP), myelin associated glycoprotein 
(MAG) etc. which play a vital role in the synthesis of myelin membrane (Fig. 1). With the 
synthesis of myelin membrane, the mature oligodendrocytes acquire a differentiated 
morphology with extensive branching and interconnections to develop into a mature 
myelinating oligodendrocyte which can adhere and myelinate the axons. The ensheathment of 
myelin around axons increases the nerve conduction velocity by saltatory conduction of the 
action potential. Normally, the myelin sheath from a single oligodendrocyte can wrap around 
one or more axons (Baumann and Pham-Dinh, 2001). 
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Figure 1: Illustration showing the developmental stages and markers expressed during oligodendrocyte 
development. Different markers are expressed on precursor, progenitor, immature and myelinating 
oligodendrocytes (Adapted from Baumann and Pham-Dinh, 2001). 
2.2 Schwann cells 
Schwann cells are the myelinating cells of the peripheral nervous system which ensheath the 
axons in the PNS. In vertebtrates, Schwann cells are derived from the neural crest and 
placodes of the head region during embryogenesis (Harrison, 1924). Schwann cells can be of 
two subtypes namely, ensheathing Schwann cells and myelinating Schwann cells. Both 
subtypes are derived from a common precursor. Ensheathing Schwann cells are associated 
with unmyelinated nerve fibers, providing ensheathment via membranous indentations on 
their surface. As the ensheathment provided by these Schwann cells is not necessary for nerve 
conduction, the exact function of these cells still remains unclear. Myelinating Schwann cells 
generate myelin and spirals around individual axons, so that unitary connection is established 
between the Schwann cell and the axon (Bung and Fernandez-Valle, 1995). 
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2.3 Neural cell adhesion molecule (NCAM) and Polysialic acid (PSA)  
2.3.1 NCAM 
NCAM is a cell adhesion molecule that belongs to the immunoglobulin super-family that 
plays a pivotal role in cell-cell interactions in various tissues. It is expressed mainly in the 
neural cells and skeletal muscle (Sanes et al., 1986). The diversity in NCAM functions is 
possible by generation of different isoforms, by alternative splicing of hnRNA from a single 
NCAM gene and by post-translational modifications. The 3 main isoforms in the brain are 
NCAM-120, 140 & 180 (Goridis et al., 1983; Gennarini et al., 1986). In the brain, NCAM-
120 is expressed in oligodendrocytes (Bhat and Silderberg, 1986) and NCAM-140 & 180, in 
neurons. The extra-cellular domain of the polypeptide chain in all 3 isoforms consists of 5 
immunoglobulin and 2 fibronectin type III like domains, respectively (Cunningham et al., 
1987; Santoni et al., 1987). NCAM-120 is attached to the membrane by a 
glycosylphosphatidylinositol (GPI) anchor and lacks a transmembrane domain while NCAM-
140 & 180 are transmembrane proteins, containing short or long cytoplasmic domains, 
respectively (Barthels et al., 1987; He et al., 1986; Hemperly et al., 1986). NCAM has been 
shown to participate in a number of developmental processes including cell migration, neurite 
outgrowth and synaptic plasticity (Crossin and Krushel, 2000; Ronn et al., 2000 and 
Schachner, 1997). NCAM carries out many of its functions by homophilic and heterophilic 
interactions with other NCAM molecules or with other cell adhesion molecules and receptors 
like L1 and fibroblast growth factor receptors and a variety of extra-cellular matrix 
components (Povlsen et al., 2003). Apart from its adhesive properties, NCAM influences the 
developmental events through its signalling properties. For example, NCAM-140 associates 
with Fyn kinase or acts as an alternative receptor for glial derived neurotrophic factor 
(GDNF) family of ligands and recruits focal adhesion kinase, a kinase known to participate in 
cytoskeletal rearrangements (Beggs et al., 1997; Paratcha et al., 2003). 
2.3.2 Polysialic acid 
Polysialic acid is a negatively charged, homopolymer of α2-8 linked sialic acid (N-acetyl 
neuraminic acid) residues attached post-translationally to NCAM (Finne et al., 1983). Besides 
brain, PSA is also expressed in heart and kidney (Finne et al., 1987; Roth et al., 1987). Two 
different sialyltransferases namely, STX (Nakayama et al., 1995) and PST (Eckhardt et al., 
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1995) catalyze addition of PSA to NCAM in the trans-Golgi compartment (Scheidegger et al., 
1994; Alcaraz and Goridis, 1991). 
2.3.2.1 PSA synthesis 
The three major building units of PSA are N-acetyl neuraminic acid (Neu5AC), 5-N- 
glycolylneuraminic acid (Neu5GC) and 5-deamino-3, 5-dideoxyneuraminic acid (2-keto-3-
deoxynonulosonic acid, Kdn). The predominant building units of PSA in mammals are 
Neu5Ac and Kdn (Mühlenhoff et al., 1998). Condensation of N-acetyl mannose-6 phosphate 
(ManNAc-6-P) or mannose-6 phosphate (Man-6-P) with activated forms of pyruvate 
generates Neu5Ac or Kdn units. The free sialic acids are then converted to activated forms of 
CMP (cytidine monophosphate)-Sia, catalysed by the enzyme CMP-Sia synthetase. The 
activated CMP-Sia is then transported from the cytoplasm to the Golgi apparatus by a CMP-
Sia antiporter. In the Golgi apparatus, sialic acid residues are transferred from CMP donors to 
proteins like NCAM by sialyltransferases like STX and PST (Varki et al., 1999). The free 
CMPs that are generated during the above reaction are transported back to the cytoplasm. 
The developmental expression of STX and PST is tightly regulated, both PST and STX are 
expressed during embryonic stages (Ong et al., 1998) whereas, in the adult brain, PST 
expression persists only in regions displaying neurogenesis and plasticity and STX mRNA is 
almost not detectable (Livingston & Paulson, 1993; Hildebrandt et al., 1998). During the 
process of maturation of oligodendrocytes the expression of PSA-NCAM is downregulated 
due to a downregulation of PST mRNA (Stoykova et al., 2001). 
2.3.2.2 Function 
PSA promotes plasticity in cell-cell interactions during axonal migration, fasciculation and 
cell migration (Kiss et al., 1997; Rutishauser and Landmesser, 1996). Due to its size and 
negative charge PSA exhibits anti-adhesive properties, thereby inhibiting cell adhesion to 
other cells and extra-cellular matrix (Yang et al., 1992; Yang et al., 1994; Johnson et al., 
2005). During spatial learning, which enhances synaptic plasticity, an increase in the number 
of PSA positive neurons is observed in hippocampus (Muller et al., 1996; Becker et al., 1996). 
Besides, it has been demonstrated that PSA is also required for long term potentiation 
(Cremer et al., 1994) and maintenance of circadian rhythm (Fedorkova et al., 2002). During 
the process of oligodendrocyte migration and differentiation oligodendrocytes are influenced 
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by a coordinated action of specific positive and negative signaling cues. While positive 
signals help the oligodendrocyte precursors to migrate and differentiate, negative signals 
prevent their premature differentiation. Among the different negative signals, polysialylated 
neural cell adhesion molecule (PSA-NCAM) is one such signal which is expressed in 
migratory oligodendrocyte precursors to facilitate their migration (Fig 1).  
2.4 Myelin 
In the CNS, oligodendrocytes synthesize a highly specialized plasma membrane called 
myelin. Myelin membrane wraps around the axons, acting as an insulator and enables 
saltatory conduction of nerve impulses thereby increasing the speed of transmission of action 
potential. Formation of myelin membrane is a tightly regulated developmental process 
involving synthesis of lipids and proteins and transport of these proteins or their mRNAs to 
the oligodendrocyte processes. The white matter in the CNS is made up of 40-50% of myelin 
on a dry weight basis. Myelin dry weight consists of 70% lipids and 30% proteins. This lipid-
protein ratio is peculiar to myelin and is generally reverse in other cellular membranes 
(Baumann and Pham-Dinh, 2001). 
2.4.1 Myelin lipids 
The myelin lipids are enriched in cholesterol, forming a higher percentage of the total lipid 
composition. Phospholipids represent 40% of the total myelin and in general are similar in 
composition to the phospholipids of the plasma membrane. Sphingolipids like sphingomyelin 
and glycosphingolipids especially, galactocerebrosides, galactosylceramide (GalC) and 
sulfatide also form a part of the myelin membrane. GalC represents 20% of lipid dry weight 
in mature myelin. Glycosphingolipids are a subtype of glycolipids, synthesized from ceramide 
that carry a cerebroside side chain. Glycosphingolipids can be subdivided into cerebrosides, 
sulfatides, globosides and gangliosides. Several minor galactolipids like the sialylated 
gangliosides, GM1 and GM4, fatty esters of cerebroside, i.e., acylgalactosylceramides and 
galactosyldiglycerides also form a part of myelin membrane. 
2.4.2 Myelin Proteins  
Myelin is rich in a variety of proteins that are specific for myelin producing cells. The major 
proteins of myelin are myelin basic protein (MBP), proteolipid protein (PLP), myelin 
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associated glycoprotein (MAG) and CNPase. Other proteins like myelin oligodendrocyte 
glycoprotein (MOG), connexin-32 and myelin associated oligodendrocyte basic protein 
(MOBP) constitutes a very small percentage of the total myelin proteins. 
MBP exists as several isoforms with molecular mass of the major isoforms being 21.5, 20, 
18.5, 17 & 14 kDa in mouse. These isoforms are generated by alternative splicing of a single 
mRNA precursor (deFerra et al., 1985; Newmann et al., 1987). MBP is a basic hydrophilic 
membrane associated protein, expressed by oligodendrocytes and some cells of the 
haematopoetic system (Marty et al., 2002). Evidence from shiverer mutant mice, where the 
different isoforms of MBP are undetectable due to mutation in the MBP gene (Molineaux et 
al., 1986), indicates that MBP plays a major role in myelin compaction in the CNS (Roach et 
al., 1985).  
Proteolipid proteins exists in two isoforms namely as a predominant, 30 kDa PLP and 25 kDa 
DM-20, produced by alternative splicing from a single gene (Nave et al., 1986; Morello et al., 
1986). PLP is an integral membrane protein. mRNA of DM-20 can be detected in the CNS at 
a very early stage of development even before the onset of myelination (Ikenaka et al., 1992; 
Peyron et al., 1997; Timsit et al., 1992; Timsit et al., 1995), but in general in mouse brain PLP 
synthesis peaks a few days later than that of MBP synthesis. The period of active myelination 
in mouse brain is around 2-3 weeks postnatally. During this period, MBP synthesis reaches its 
peak at around 18 days when compared to PLP, which is 22 days. Analysis of PLP knock-out 
mice shows that PLP plays a role in stabilizing membrane junctions after myelin compaction 
(Boison et al., 1994; Boison et al., 1995). 
Myelin associated glycoprotein (MAG) exists in two forms as L-MAG and S-MAG with 
molecular masses of 72 and 67 kDa, respectively. In the CNS, L-MAG is the major form 
during early myelinogenesis and S-MAG expression increases with maturation, so that in the 
adult, the two isoforms are expressed in equal amounts. In the PNS, S-MAG is the 
predominant isoform at all stages of development (Frail et al., 1985; Salzer et al., 1987). L-
MAG is shown to be involved in the activation of Fyn kinase, which implicates the tyrosine 
phosphorylation cascade involved in myelinogenesis, maturation and differentiation of 
oligodendrocytes (Umemori et al., 1994). MAG is proposed to perform neuron-
oligodendrocyte interactions through its sialic acid binding site at arginine-118 amino acid 
(Poltorak et al., 1987; Tang et al., 1997). MAG interacts with sialylated glycolipids like 
gangliosides or with sialylated proteins (Yang et al., 1996) and carry out these interactions. 
MAG is also shown to inhibit axon regeneration after lesion (Filbin, 1996; Qiu et al., 2000). 
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Analysis of myelin sheaths from MAG knock-out mouse showed that there was a delay in 
myelin compaction indicating that MAG might play a role in myelin compaction (Li et al., 
1994; Montag et al., 1994). 
2’, 3-cyclic nucleotide 3-phosphodiesterase (CNPase) or RIP antigen (Watanabe et al., 2006) 
is a myelin-associated protein, expressed in oligodendrocytes and Schwann cells in the CNS 
and PNS, respectively. It exists in two isoforms, produced by alternate splicing, CNP1 and 
CNP2, with molecular masses of 46 kDa and 48 kDa, respectively. CNPase comprises 4% of 
the total protein present in myelin (Baumann and Pham-Dinh, 2001). Transgenic 
overexpression of CNPase in mice perturbs myelin formation and creates aberrant 
oligodendrocyte membrane expansion (Gravel et al., 1996). 
2.4.3 Myelination in the CNS  
The process of myelination progresses in a coordinated manner. Although the actual process 
of myelination is still not clearly understood, published reports show that it involves the 
following sequential steps like migration of oligodendrocytes towards axons, adhesion of 
oligodendrocytes processes with the axon and not with the dendrites and spiralling of these 
processes around axons with a predetermined thickness. In mouse, myelination starts at birth 
in the spinal cord and is complete by 45-60 days postnatally in brain. As the oligodendrocytes 
undergo differentiation from preoligodendrocytes to immature oligodendrocytes, they lose 
their capacity for migration and cell division. During this time, they synthesize myelin sheaths 
which express myelin specific genes like CNPase and Carbonic anhydrase II (CAII) (Sprinkle 
et al., 1989; Friedman et al., 1989; Butt et al., 1995). Axonal contact is vital for the survival of 
these immature oligodendrocytes (Burne et al., 1996). Axon-oligodendrocyte cross-talk is 
important for proper positioning of oligodendrocytes around unmyelinated axons and 
ensheathment of myelin around axons. Although it is still not clear which signaling cues help 
the oligodendrocytes to distinguish between axons which must be myelinated and those which 
should not be myelinated, reports suggest that the downregulation of Jagged1, a Notch 
receptor ligand, on axons, plays a role for oligodendrocytes to establish contact with axons 
and myelinate them (Schwab et al., 1989; Wang et al., 1998). Besides Jagged1, PSA-NCAM 
has been shown to negatively regulate myelination in the CNS. During development, axons 
express PSA-NCAM but later the axonal expression of PSA-NCAM goes down so that 
myelination occurs only on PSA-NCAM negative axons. Charles et al., (2000) showed that 
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myelination is controlled by both positive signals like electrical activity and negative signals 
like PSA-NCAM expression. Data from primary neuron-oligodendrocyte co-culture analysis 
from mice showed that PSA-NCAM level on axons is downregulated at the time of 
myelination. This was further confirmed by EndoN removal of PSA, which resulted in an 
increase in the number of myelinated internodes in these cultures. Removal of PSA in cultures 
treated with tetrotoxin, an action potential blocker, were unable to reverse the inhibition of 
myelination. Moreover, in vivo examination with optic nerve showed that the time of 
appearance of first MBP positive myelinated internodes coincided with the disappearance of 
PSA-NCAM on axons and later myelination occurred only on PSA-NCAM negative axons. 
Thus, these results show that downregulation of PSA-NCAM on axons is an important signal 
for myelination but removal of PSA-NCAM alone is not sufficient to promote myelination. 
Reports show that binding of adenosine from electrically active neurons to adenosine 
receptors on oligodendrocytes prevents oligodendrocyte proliferation and initiate 
differentiation. Adenosine acts as a potent neuron-glial transmitter that inhibits 
oligodendrocyte proliferation and stimulates differentiation and myelin formation (Stevens et 
al., 2002). Apart from neurons, astrocytes also play a role in myelination by aligning the 
oligodendrocytes with axons (Meyer-Franke et al., 1999). Upon axonal recognition, mature 
myelinating oligodendrocytes with flattened, extended myelin sheaths are formed (Bunge et 
al., 1962; Bunge, 1968). A single mature oligodendrocyte wraps around more than one axon 
with different diameters of myelin. Hence, the maintenance of myelin sheath thickness is an 
important step during myelination. Axons seem to play a role in this process by specifying the 
number of myelin lamellae formed by a single oligodendrocyte (Waxman and Sims, 1984). 
Although in the peripheral nervous system, the epidermal growth factor like ligand, 
neuregulin-1-type III, expressed on axons plays a role in Schwann cell differentiation and 
regulation of myelin sheath thickness, by binding to ErbB receptor tyrosine kinases on 
Schwann cells, its role in CNS is still an open question that remains to be answered (Nave and 
Salzer, 2006). 
Despite complete ensheathment of axons with myelin, certain regions of axons called the 
nodes of Ranvier are not wrapped with myelin. The nodes of Ranvier are clustered with 
sodium channels in nodes and potassium channels in paranodes at regular intervals. As the 
myelin ensheathed regions of the axon membrane contain almost no sodium channels, they 
are not excitable; hence they have a low capacitance and a high resistance to current leakage. 
Thus, when an action potential is triggered at a node, the resulting current can be conducted to 
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the next node efficiently. Hence, the formation and maintenance of these nodes and the 
clustering of ion channels are one of the critical factors for the saltatory conduction of action 
potentials. Published reports show that signals from oligodendrocytes during their contact 
with axons generates the clustering of these ion channels (Kaplan et al., 1997). 
 
Figure 2:  Illustration of neuron and myelin sheath. An illustration depicting the basic structure of neuron, 
myelin sheath and the nodes of Ranvier.  
2.4.4 PSA and myelination 
Charles et al., (2000) showed that PSA-NCAM is downregulated on axons before the onset of 
myelination. Oligodendrocyte precursor cells (OPCs) express PSA-NCAM, but as the OPCs 
undergo differentiation to become mature myelinating oligodendrocytes, PSA-NCAM is 
downregulated. Since PSA-NCAM is downregulated during early differentiation, the role 
played by PSA-NCAM in the process of myelination is still not clear. The question whether 
PSA-NCAM downregulation in oligodendrocytes, as in axons, is a necessary prerequisite for 
myelination still needed to be answered. Reports from Stoykova et al., (2001) show that the 
polysialyltransferase, PST, is responsible for the polysialylation of NCAM in 
oligodendrocytes. Hence, in order to address the question about the role played by PSA 
downregulation in oligodendrocytes on myelination, in this study, PST transgenic mice under 
the control of PLP, a marker for mature differentiated oligodendrocytes, promoter was 
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generated; so that, these mice sustain the expression of PST and the NCAM remain 
polysialylated even in mature differentiated oligodendrocytes. 
2.4.5 Myelin disorders 
The process of myelin formation and myelination is well synchronized that alterations in the 
synthesis or degradation of the myelin lipids and proteins leads to several myelin related 
disorders resulting in demyelination or dysmyelination or hypomyelination and uncompaction 
of myelin. The causes for these disorders could be due to a variety of factors like genetic, 
lesion, trauma, inflammation, malnutrition, viral infections, toxicity or improper metabolism 
of lipids and proteins. Among the several myelin disorders, leukodystrophies are a group of 
inherited disorders characterised by loss of myelin in CNS and PNS. Leukodystrophies can 
occur due to dysfunction in lipid metabolism as in metachromatic leukodystrophy, Krabbe’s 
disease and adrenoleukodystrophy, or in protein metabolism as in Pelizaeus Merzbacher 
disease and Alexander’s disease. 
2.5 Metachromatic leukodystrophy (MLD) 
Metachromatic leukodystrophy (MLD) is an autosomal recessively inherited lysosomal 
storage disorder caused by the deficiency of an enzyme Arylsulfatase A (ASA). ASA is an 
enzyme responsible for the degradation of sulfatide. Hence, the deficiency of this enzyme 
leads to storage of the sphingolipid sulfatide in nervous system and several other organs. The 
disease is characterized by progressive demyelination in both CNS and PNS, resulting in 
severe neuropathological symptoms in humans. The frequency of the disease is 1:40,000 to 1 
in 100,000 newborns (von Figura et al., 2001). 
2.5.1 Classification  
MLD in human patients is classified depending on the age of onset into four forms of disease 
namely (a) late infantile, between 6 months and 4 years, (b) early juvenile, between 4 and 6 
years, (c) late juvenile, between 6 and 16 years and (d) adult, older than 16 years. In all these 
forms, the disease is characterized by deficient ASA activity, decreased nerve conduction 
velocity, increased cerebrospinal fluid protein and increased excretion of urinary sulfatide. 
Besides these symptoms, ataxia, gait disturbance, progressive demyelination and optic 
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atrophy are the other manifestations of the disease. Table 1 indicates the characteristic 
features of different types of MLD. 
Characteristics of late infantile, juvenile and adult forms of MLD 
Table 1 
 
Adapted from The metabolic and molecular basis of inherited diseases: Metachromatic 
leukodystrophy, von Figura et al., 2001. 
2.5.2 Pathology 
The major hallmark of the disease is the progressive demyelination and deposition of 
metachromatic granules in central and peripheral nervous system. The metachromatic 
granules from MLD brain contain sulfatide amounting to 39% of their total lipid content. 
Electron microscopy of the storage granules shows characteristic prismatic and tuffstone like 
profiles and composite bodies containing lipofuscin. In the CNS, the amount of white matter 
is reduced, is firmer and show cavitation or spongiform degeneration in the affected areas, 
with accumulation of metachromatic granules in the oligodendrocytes, neurons and 
macrophages. Demyelination is observed in brain stem, spinal cord and cerebellum. The 
cerebellum is atrophic and shows prominent gliosis in demyelinated areas, with reduction in 
the number of Purkinje and granule cells. The PNS shows segmental demyelination with 
accumulation of metachromatic granules in Schwann cells and reduced myelin sheath 
thickness. Apart from the nervous system, storage of sulfatide is also observed in the visceral 
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organs like kidney, gall bladder, islets of Langerhans, anterior pituitary, adrenal cortex, testes 
and sweat glands. 
In late infantile patients, the white matter sulfatide level is increased 3 to 4-fold, along with a 
marked decrease in myelin lipids like cholesterol and sphingomyelin.  There is also a drastic 
reduction in cerebroside, hence, GalC:sulfatide ratio is reduced to one in late infantile form of 
MLD patients when compared to three in normal individuals (Harzer et al., 1987; Norton et 
al., 1982). In adults, the white matter sulfatide is only moderately increased when compared 
to normal white matter (Pilz and Heipertz, 1974) and contains more short chain and saturated 
and less unsaturated fatty acids (Malone et al., 1966). Moreover, sulfatide concentration is 
also increased in gallbladder, kidney and urine of MLD patients (von Figura et al., 2001). 
2.6 Arylsulfatase A 
Arylsulfatase A (ASA) is a cerebroside sulfatase found in lysosomes that cleaves the sulfate 
group in sulfatides, lactosylceramide 3-sulfate and seminolipids. Desulfation of sulfatide by 
ASA leads to the degradation of sulfatide to galactosylceramide (GalC). Arylsulfatases are 
expressed in all body tissues and fluids. During the period of myelination, ASA activity 
increases steadily with CST enzyme activity. After completion of myelination, CST activity is 
reduced whereas ASA activity is not.  
The human ASA gene is located on chromosome 22 and consists of 8 exons. The gene is 
transcribed into a 2.1 kb mRNA, which in turn codes for the ASA precursor protein of 507 
amino acids. Post-translational modifications take place in the endoplasmic reticulum, 
including the oxidation of thiol group to an aldehyde at the cysteine 69 amino acid of ASA 
protein. This oxidation generates a formylglycine residue at cysteine 69 position, which is 
important for ASA enzyme activity (Dierks et al., 1997). Within the lumen of the 
endoplasmic reticulum, the signal peptide is cleaved and N-oligosaccharide side chains are 
added at three potential N-glycosylation sites. After completion of protein folding, the 
enzyme is transported to the Golgi apparatus and recognized by lysosomal phosphotransferase 
as a lysosomal enzyme and mannose-6-phosphate residues are added to the N-oligosaccharide 
side chains. The addition of mannose-6-phosphate occurs in a two step reaction involving 
transfer of N-acetylglucosamine 1-phosphate from UDP-N-acetylglucosamine to mannose 
residues of N-linked oligosaccharides by a phosphotransferase (UDP-N-acetylglucosamine: 
lysosomal enzyme N-acetylglucosamine-phosphotransferase), followed by removal of N-
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acetylglucosamine by N-acetylglucosaminidase, which generates mannose-6-phosphate 
residues on ASA. The mannose-6-phosphate residues are recognized by mannose-6-phosphate 
receptors and ASA is then transported in vesicles to lysosomes.  
ASA is an acidic glycoprotein with low isoelectric point. The major substrates of ASA are 
sulfatide, galactosyl-3-O-sulfates (lactosyl ceramide 3-sulfate, seminolipid and lysosulfatide) 
and ascorbic acid-2-sulfate. Till date, more than 80 different mutations have been found in the 
ASA gene that causes MLD in humans (von Figura et al., 2001). 
2.7 Cerebroside sulfotransferase (CST) 
CST is a Golgi-associated sulfotransferase, whose activity has been demonstrated in brain, 
testis, kidney, liver, gastric mucosa, lung and endometrium of various mammals (Ishizuka, 
1997). The major sulfoglycolipids synthesized by CST are sulfatide, seminolipid (3-O-
sulfogalactosyl glycerolipid) and lactosylceramide 3-sulfate. The mouse CST gene is 
composed of 3 exons with exon 1 existing in 7 multiple forms at the 5’untranslated region 
contributing to tissue specific splicing of CST transcripts. The protein is made of 423 amino 
acids with a molecular weight of 48,995 daltons (Hirahara et al., 2000). 
2.8 Sulfatide 
Sulfatide is an acidic glycosphingolipid, whose sphingosine base is predominantly made up of 
C-18 sphingosine. It is a sulfatide ester of galactocerebroside with the sulfate joined by an 
ester linkage to the C-3 hydroxyl of galactose. Sulfatide accounts for 3-4% of myelin lipids in 
the nervous system (Norton and Poduslo, 1982). Maximum synthesis of sulfatide occurs 
during myelination and proceeds more slowly in the adult. Besides brain, sulfatide is 
abundant in the kidney (von Figura et al., 2001). Sulfatide synthesis begins with the addition 
of galactose residues to ceramides by UDP-galactose:ceramide galactosyltransferase (CGT), 
in the endoplasmic reticulum; resulting in the formation of Galactosylceramide (GalC). GalC 
is then transported from the endoplasmic reticulum to the Golgi apparatus where sulfate 
groups are added to it. This reaction is catalyzed by galactosylceramide 3’- sulfotransferase 
(CST), a Golgi enzyme, by transferring the sulfate from PAPS: 3’-phosphoadenosine 5’- 
phosphosulphate to GalC. PAPS, is a sulphonate donor, synthesized from the catalytic 
reaction of PAPS synthetase and ATP in the Golgi apparatus (Fuda et al., 2002).  
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Figure 3: Sulfatide: structure, synthesis and degradation. A schematic diagram showing (A) sulfatide 
structure and (B) synthesis and degradation of sulfatide. 
Sulfatide is transported from the Golgi apparatus to lysosomes, myelin membrane and plasma 
membrane in vesicles (Burkart et al., 1982). It is located on the outer leaflet of myelin 
membrane and is probably bound to MBP and PLP proteins by strong ionic interactions (von 
Figura et al., 2001). Sulfatide is first expressed when OPCs cease to proliferate and 
commence terminal differentiation. Analysis of CST knock-out [CST(-/-)] mice by Hirahara 
et al., (2004) show that there is a 2-3 fold enhancement in the number of terminally 
differentiated oligodendrocytes both in oligodendrocyte cultures and in vivo, indicating that 
sulfatide acts as a negative regulator of oligodendrocyte differentiation. Moreover, results 
from (Ishibashi et al., 2002; Honke et al., 2002; Marcus et al., 2006) show that CST(-/-) mice 
display abnormalities in paranodal junction formation and a decrease in Na+ and K+ ion 
channel clustering. These results show that sulfatide is essential for the maintenance of 
myelin, paranodal loops and clustering of sodium and potassium channels of the myelin 
membrane.  
Sulfatide is also believed to be involved in active sodium transport, serving as a co-factor for 
Na/K-ATPase (Rintoul et al., 1989). Moreover, sulfatide also binds to various cellular 
adhesion molecules like laminin, selectin, thrombospondin and tenascin R (von Figura et al., 
2001). 
Ceramide 
CGT
UDP galactose UDP
Galcer
CST/PAPS
Sulfatide
ASA 
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2.9 Animal model of MLD 
An animal model for MLD, till date, is the ASA(-/-) mice deficient in ASA. The ASA(-/-) 
mice exhibit several characteristics of the human disease. These mice store sulfatide in the 
nervous system; in neurons, oligodendrocytes and Schwann cells, as well as in kidney and 
gall bladder (Hess et al., 1996). Mice between 6 and 12 months of age develop neuronal and 
glial degeneration of the acoustic ganglion, resulting in deafness. In older animals, 2 years of 
age, neuromotor alterations, ataxia, shorter gait and cerebellar deficits were observed 
(D’Hooge et al., 1999). Although the animals accumulate increasing amounts of sulfatide 
with age, they display less severe symptoms and their pathology did not reach the advanced 
stages of MLD, like slowed nerve conduction velocity, progressive hindlimb paralysis and 
progressive demyelination that are characteristics of the disease in human MLD patients. 
Thus their sulfatide storage pattern resembles that of human late infantile (early onset) MLD 
patients (Hess et al., 1996).  
2.9.1 Improved animal model of MLD 
Sulfatide storage is a critical criterion for the disease manifestation in human patients. Since 
the ASA(-/-) mouse show sulfatide storage similar to early phase of human MLD, in this 
study it was hypothesized that by increasing sulfatide storage in ASA(-/-) mice an improved 
animal model for human MLD could be generated that would display the neuropathology of 
late stages of the disease including progressive demyelination. The increase in sulfatide 
synthesis could be achieved either by overexpressing CGT or CST genes. Recent published 
reports (Fewou et al., 2005) showed that CGT transgenic mice demyelinate even with a 
functional ASA gene and do not show a net accumulation of sulfatide. Hence the increase in 
sulfatide synthesis was achieved by generating transgenic/ASA(-/-) [tg/ASA(-/-)] mice that 
would overexpress CST under the control of PLP promoter, so that these mice increase 
sulfatide storage in oligodendrocytes and Schwann cells. Hence, transgenic mice 
overexpressing CST in oligodendrocytes under the control of PLP-promoter was generated 
and bred with ASA(-/-) mice, to increase the sulfatide level. These mice were then analyzed 
in detail in the present study. 
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3. Materials and methods 
3.1 Chemicals used 
Unless otherwise stated chemicals were purchased from Serva (Heidelberg, Germany), Merck 
(Darmstadt, Germany), Fluka (Germany), BioRad Laboratories (Munich, Germany). 
All cell culture solutions, buffers, DNaseI, antibiotics & horse serum are from Sigma 
(Deisenhofen, Germany), Invitrogen/Life technologies (Karlsruhe, Germany) & GibcoBRL 
(Karlsruhe).  
In vitro transcription kit was from Roche (Basel, Switzerland) & Boehringer (Mannheim). 
[α-32P]-dCTP & [35S]-Na2SO4 were obtained from Amersham (Buckinghamshire, UK). 
Restriction enzymes, PCR reaction mix (Buffers, dNTPs, Taq polymerase enzyme, MgCl2), 
RT-PCR kit, protein and DNA markers were from Fermentas (St.Leon-Rot, Germany). 
3.2 Equipments and Materials used 
Equipments and Materials     Company 
ABI prism 310 genetic analyzer  Perkin Elmer 
AIDA software      Raytest 
Beckmann DU 640 spectrophotometer   Beckmann Coulter 
Biomax MR film      Kodak 
Block heater       Stuart Scientific   
CAMAG automatic TLC sampler    CAMAG 
Cell culture plates/flasks     Sarstedt 
Centricon spin columns     Millipore 
Centrifuge 
Eppendorf 5810R, 5417R and 5415 D  Eppendorf 
Optima TLX ultracentrifuge    Beckmann Coulter 
Ultracentrifuge L7-65    Beckmann Coulter 
Sorvall GS3, JA-10 suppressed   Heraeus Sorvall 
Cryostat CM 30                                                                     Leica  
Digital balance      Typ 126MP; 1265-Sartorius 
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Electrophoresis apparatus-agarose gels  Hoefer Scientific Instruments 
Electrophoresis apparatus for SDS-PAGE   BioRad 
ELISA reader       BioRad 
Film Developer Curix 60     Agfa 
Freeze drier (LYO-VAC)     Amsco/finn-Aqua       
Gel blot system      BioRad 
Gel dryer       Savant 
Haemocytometer      Hausser 
Hi Trap Ni2+-chelating column    Amersham Pharmacia 
Homogeniser       Janke & Kunkel 
HPTLC plates  (Silica gel 60)    Merck 
Hyper Cassette      Amersham 
Ice machine AF–10      Scottsman 
Imaging plates BAS IP MS 2325    Fuji Photo film 
Laminar flow system-type CA/REV6   Clean Air 
Magnetic stirrer      Janke & Kunkel 
Micro pipettes      Gilson 
Microscope Axiovert 100 M     Zeiss 
Microwave oven      Sharp 
PAPPEN       Dakocytomation 
Pasteur pipettes      Assistent 
Petri plates       Sarstedt 
Pipettes (10µl, 200µl, 1000µl)    Heinrich EM 
Pipette tips       Greiner 
PEI TLC plates      Merck 
pH-Meter (Digital-pH-Meter 646)    Knick 
Phosphorimager ES 1000     Raytest 
Scintillation counter Beckmann LS-6500   Beckmann 
Shaking water bath      Köttermann 
Speed vac SC-100      Savant 
Sterile hood Labgrade class II, Typ A/B3   Nuaire 
Super Frost Plus glass slide     Menzel-Glaser 
Thermocycler T3      Biometra 
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Ultrasonicator       Branson Ultrasonic SA    
UV hand lamp      Konrad Bender  
Vortexer       Heidolph 
Water purifier Milli-Q Plus     Millipore 
3.3 Buffers and solutions 
Table 2 
Tris (hydroxyl methyl)-aminoethane  
buffered saline (TBS) 
20 mM Tris-HCl, pH 7.4 
150 mM NaCl 
10x Phosphate buffered saline (PBS) 100 mM Na2HPO4/NaH2PO4, pH 7.4, 1.5 M NaCl, 
25mM KCl 
1x TAE 40 mM Tris-base, 20 mM acetic acid, 1 mM EDTA, 
pH 8 
TNE 10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM 
EDTA, 1 mM PMSF 
20x SSC 3 M NaCl, 0.3 M  Sodium citrate, pH 7.0 
10x HEPES 100 mM HEPES, 20 mM EGTA, pH 7.4 
SDS Blotting buffer 48 mM Tris-base, 39 mM Glycine, 0,037% SDS 
20% Methanol 
(4x) L4 DNA loading dye 0.25% Bromophenol blue, 30% Glycerol (100%),  
100 mM Tris-HCl, pH 7 
Lysis buffer 50 mM MgCl2, 5 mM DTT, 1 mM PMSF, 0.5 mg/ml 
lysozyme, 1.7 U/ml DNase, 150 mM NaCl 
Binding buffer 50 mM phosphate buffer, pH 8, 300 mM NaCl,  
20 mM imidazole 
Elution buffer 50 mM phosphate buffer, pH 8, 300 mM NaCl,  
500 mM imidazole, 50 mM EDTA, pH 8 
10x TE Buffer 100 mM Tris-HCl, pH 7.6, 10 mM EDTA 
Ponceau S solution 0.2% Ponceau S, 3% Trichloroacetic acid 
DEPC water 0.1% DEPC in ddH2O. Mix it o/n at RT and then  
autoclave 
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4x Protein loading dye 8% SDS, 40% glycerol, 240 mM Tris-HCl, pH 6.8 
4% Bromophenol blue, 4% β-mercaptoethanol 
LB-Medium 10 g Bacto-Tryptone, 5 g Bacto-Yeast Extract 
10 g NaCl 
in 1000 ml ddH2O; pH 7.5; autoclave the solution 
Agar plates 
 
1.5% Agar in LB-Medium 
Autoclave. Cool the solution to 50°C and pour in Petri 
plates to dry 
Antibiotics for selection 
 
Ampicillin-100 µg/ml, Kanamycin-50 µg/ml 
To either LB medium or LB agar plates 
SDS-PAGE running buffer 192 mM glycine, 25 mM Tris, 0.1% SDS, pH 8.3 
3.4 Protease inhibitors 
These inhibitors were added to buffers and solutions during protein preparations 
2 mM PMSF in methanol 
1 µg /ml Aprotinin 
1 µg /ml Leupeptin 
200 mM Pefabloc 
5 mM EDTA 
3.5 Animals and their genetic background 
All animal experiments were approved by the local committee for animal welfare 
(Bezirksregierung Köln). 
PLP-PST transgenic line - CBA x C57BL/6 
PLP-CST transgenic line - CBA x C57BL/6 x 129Ola 
ASA(-/-) mice - 129Ola 
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3.6 Chemical competent cells 
Table 3 
Strains Genotype 
BL-21 E. coli B F- dcm ompT hsdS(rB-mB-) gal 
XL1Blue supE44 hsdR17 recA1 endA1 gyrA46 thi relA1 lac F’[proAB+, laclq 
lacZΔM15 Tn10 (tetr)] 
3.7 Antibodies, their source and dilutions used 
Antibodies were used for Western blotting and immunofluorescence microscopy 
Table 4 
Antibody Source Dilution used 
m735 (PSA), mouse  
monoclonal 
Rita Gerardy-Schahn 3 µg/ml – Western, 1:500 – 
Immunofluorescence 
MBP, rabbit monoclonal  Chemicon (Hofheim, 
Germany) 
1:5,000 – Western, 1:200 – 
Immunofluorescence 
Rabbit Fyn 
Mouse CNPase 
Santacruz Biotechnology, 
USA 
1:200 – Western 
1:1,000 – Western 
NCAM H28 (BSP2) – 
hybridoma cell culture 
supernatant 
Rita Gerardy-Schahn 1:3 – Western, undiluted – 
Immunofluorescence 
Rat ENCAM BD Pharmingen, 
Germany 
1:200 – Immunofluorescence 
β-actin, mouse monoclonal 
GFAP,  mouse monoclonal  
Mouse Na+ Channel (PAN) 
Sigma, (Taufkirchen, 
Germany) 
1:4,000 – Western 
1:2,000 – Western 
1:500 – Immunofluorescence 
Rabbit Paranodin Arthur Butt 1 :1,000 – 
Immunofluorescence 
Rabbit L-MAG Arthur Butt 1:100 – Immunofluorescence 
POD conjugated anti-mouse 
POD conjugated anti-rabbit 
Cy3 conjugated goat anti- 
Jackson Laboratories, 
USA 
1:5,000 – Western 
1:10,000 – Western 
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rabbit ; Cy2 conjugated anti- 
rat ; Cy3 conjugated anti- 
mouse 
Cy2 conjugated anti-rabbit 
POD conjugated anti-rat 
1:400 – Immunofluorescence 
 
 
1:200 – Immunofluorescence 
1:10,000 – Western 
Alexa Fluor 594 anti-rat IgM 
Alexa Fluor anti-rat 488 
Molecular Probes, 
Germany 
1:200 – Immunofluorescence 
1:400 – Immunofluorescence 
3.8 Molecular Biology Methods 
3.8.1 Genotyping 
Metallic ear marks were used for labelling mice. One cm of mouse tail was cut and genomic 
DNA was extracted by incubating the tail with 750µl lysis buffer (10 mM Tris-HCl, 100 mM 
NaCl, 25 mM EDTA, pH 8, 1% SDS, 100 µg/ml proteinase K) at 56°C, o/n. 250µl of 6M 
NaCl was added to the lysed samples and incubated at 56°C for 5 min. The samples were 
centrifuged for 10 minutes at RT and 750µl of supernatant was collected and 500µl of 
isopropanol was added to the supernatant to precipitate the DNA. Genomic DNA was fished 
out with an yellow tip and immersed into 70% ethanol and allowed to air dry and was re-
suspended in HPLC grade water.  
3.8.2 Polymerase chain reaction (PCR) 
For genotyping PLP-PST mice, PST sense and PST antisense primers were used. To genotype 
PLP-CST mice crossed with ASA(-/-) mice, CST1 sense, CST2 antisense, ASA sense, ASA 
antisense and ASA neo primers were used in one PCR reaction mix. PST sense and PST 
antisense primers were used to genotype PLP-PST mice. 
PCR reaction mix 
100-500 ng genomic DNA or 1.5 µl cDNA    
2.5 µl of 10x PCR buffer   
2.5 µl of 2 mM dNTPs 
0.1 µl of 100 pmol/µl primers 
5µl of 25 mM MgCl2 
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1.5 µl of 1 U/µl Taq polymerase (for all PCR reactions) or 0.25 µl Phusion polymerase (MBP 
PCR). Volume was made up to 25 µl with HPLC grade water. 
3.8.2.1 List of primers used for PCR reactions 
Table 5 
Primers Sequence 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ASA sense 5’ TAGGGTGGAAGTTACCCTAGA 3’ 
ASA antisense 5’ TGACCCAGGCCTTGTTCCCAT 3’ 
ASA neo 5’ GGAGAGGCTATTCGGCTATGAC 3’ 
PST sense 5’ CCATGCGCTCAATTAGAAAACG 3’ 
PST antisense 5’ GCTCTAGATTATTGCTTCATGCACT   
TTCC 3’ 
CST1 sense 5’ ATGACTCTGCTGCCAAAGAAGC 3’ 
CST2 antisense 5’ CCACCTTAGAAAGTCCCTAAGG 3’ 
MBP sense 5’ GCCTGGATGTGATGGCATCAC 3’ 
MBP antisense 5’ AGGTGCTTCTGTCCAGCCATAC 3’ 
β-actin sense 5’ TCCATCATGAAGTGTGACGT 3’ 
β-actin antisense 5’ GAGCAATGATCTTGATCTTCAT 3’ 
eEF2 sense 5’ GCCGAGCGTGCCAAGAAAGTAG  3’ 
eEF2 antisense 5’ AGCCTTGAGCAATGGCTTGCCC 3’ 
eIF1A sense 5’ TGGACGGTTGGAAGCAATGTGC 3’ 
eIF1A antisense 5’ TCAAGATGCCACTGTGTGGAGC 3’ 
eIF4A2 sense 5’ CGTGGGATTGACGTGCAACAAG 3’ 
eIF4A2 antisense 5’ ATTCAGCAACAGCGAGCACTGC 3’ 
eIF2 su 3 sense 5’ AACGATAGCAGAAAGGGGCACC 3’ 
eIF2 su 3 antisense 5’ TGGGGCCGATGTTTGTTCCAAC 3’ 
eIF4b sense 5’ CAACTGATGGGCTTGGGTGGTG 3’ 
eIF4b antisense 5’ CCGGAGAAGCGATTTGCTGTGC 3’ 
TGF-β III receptor sense 5’ ATGGCAGTGACATCCCACCA 3’ 
TGF-β III receptor antisense 5’ TCCGAAACCAGGAAGAGTCT 3’ 
SP6 5’ CTAGCATTTAGGTGACACTATAG 3’ 
T7 5’ TAATACGACTCACTATAGGG 3’ 
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3.8.2.2 Genotyping of PLP-CST and PLP-PST mice 
Table 6 
Target Primers PCR conditions PCR products 
Mouse 
genomic DNA 
CST1 sense, 
CST2 antisense, 
ASA sense, ASA 
antisense, ASA 
neo 
94°C for 5min 
94°C for 30 sec     32 
56°C for 30 sec     cycles    
72°C for 1 min 
72°C for 10 min 
CST-transgene -1270 bp 
ASA wild-type - ~ 480 bp 
ASA knock-out - ~1100 bp 
Mouse 
genomic DNA 
PST sense, PST 
antisense 
94°C for 5min 
94°C for 30 sec     32 
56°C for 30 sec     cycles    
72°C for 1 min 
72°C for 10 min 
PST-transgene - ~1100bp 
 
The above PCR products from table 6 were analysed on a 1% agarose gel containing 0.5 
µg/ml ethidium bromide. 
3.8.2.3 PCR reactions for TGF-β III receptor, β-actin, elongation factors, initiation 
factors and MBP 
Table 7 
Target Primers PCR conditions PCR product 
 
 
 
cDNA 
 
 
TGF-β-III sense, 
TGF-β-III antisense 
β-actin sense, β-actin 
antisense 
94°C for 5min 
94°C for 1min        30 
56°C for 1 min      cycles   
72°C for 1 min 
72°C for 10 min 
TGF-β III receptor - 397 bp 
 
 
β-actin -153 bp 
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cDNA 
eIF1A sense, eIF1A 
antisense 
eEF2 sense, eEF2 
antisense 
eIF2 su 3 sense, eIF2 
su 3 antisense 
eIF4A2 sense, 
eIF4A2 antisense 
eIF4b sense, eIF4b 
antisense 
94°C for 5min 
94°C for 1 min      25 
56°C for 1 min      cycles   
72°C for 1 min 
72°C for 10 min 
eIF1A - 367 bp 
 
eEF2 - 276 bp 
 
eIF2 su 3 - 402 bp 
 
eIF4A2 - 269 bp 
 
eIF4b - 424 bp 
cDNA MBP sense, MBP 
antisense 
94°C for 5min 
94°C for 1min       32 
60°C for 1 min      cycles   
72°C for 1 min 
72°C for 10 min 
MBP - 2032 bp 
 
 
 
PCR reactions for TGF-β III receptor, β-actin, elongation and initiation factors were carried 
out separately in different reaction tubes. Except for MBP (which was run on a 1% gel), the 
other PCR products from table 7 were analysed on a 2% agarose gel containing 0.5 µg/ml 
ethidium bromide. 
3.8.3 RT-PCR (Reverse transcription-polymerase chain reaction) 
RT was done with RevertAid H minus first strand cDNA synthesis kit (Fermentas Life 
Sciences, Leon-Rot, Germany). To 5 µg of total RNA from wild-type CBAxBL/6x129Ola 
mouse, 1 µl of oligo (dT)18 primers was added. Volume was made up to 12 µl with RNase- 
free DEPC-treated water. The mixture was incubated at 70°C for 5 min, chilled on ice and 
was briefly centrifuged. Four µl of 5x reaction buffer, 1 µl of ribonuclease inhibitor (20 U/µl) 
and 2 µl of 10 mM dNTP mix was added and the mixture was briefly centrifuged. The 
reaction mix was incubated at 37°C for 5 min and 1 µl of RevertAid H minus-MuLV reverse 
transcriptase (200 U/µl) enzyme was added and incubated at 42°C for 60 min. Reverse 
transcription reaction was stopped by incubating at 70°C for 10 min. PCR reactions for TGF-
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β III receptor, elongation factors, initiation factors, β-actin and MBP, were carried out with 
1.5 µl of the above synthesized cDNA (Table 7). 
3.8.4 Spectrophotometric quantification of nucleic acids 
Quantification of DNA/RNA can be done spectrophotometrically by measuring the 
absorbance. DNA/RNA absorbs light in ultraviolet range (200-400nm) with an absorption 
peak at 260nm and proteins have an absorption peak at 280nm. Hence, by measuring the 
absorbance at 260nm and 280nm and calculating the OD260/OD280 ratio (Kalckar´s formula) 
the purity of the nucleic acid sample can be determined. The ideal ratio for a pure DNA or 
RNA preparation is 1.8 to 2.0; samples contaminated with protein’s have a lower value. The 
concentration of DNA or RNA can be determined by Beer Lambert’s law 
 
        E = εcl     E = Extinction 
ε = extinction coefficient [L mol-1 cm-1] 
c = concentration of sample [mol L-1] 
l = length of light pathway in centimetres [cm] 
An OD260nm measurement of 1.0 with l = 1 cm corresponds to approximately 
50 μg/ml double stranded DNA 
40 μg/ml single stranded DNA or RNA 
33 μg/ml single stranded oligonucleotides 
3.8.5 Restriction digestion 
Restriction enzymes are endonucleases, which recognize specific, often palindromic 
sequences in double stranded DNA and cleave these sequences by hydrolysis of the 
phosphodiester bonds in DNA. Three kinds of restriction endonucleases designated Type I, 
Type II and Type III are currently known. 
Of the 3 types, only Type II is used in molecular cloning. Typical Type II restriction enzymes 
recognize specific DNA sequences that are 4,5,6,8 or more nucleotides in length. The location 
of cleavage sites within a sequence differs from one enzyme to the other. Some enzymes 
cleave both strands exactly in the middle of the sequence creating fragments with blunt ends, 
while others cleave at similar locations which are some base pair’s apart on the opposite 
strands of the DNA creating DNA fragments with single stranded termini (sticky ends). One 
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unit of restriction enzyme is defined as the amount of enzyme needed to hydrolyze 1μg λDNA 
at 37°C in one hour.  
Restriction digestion of pBluescript SK(-) vector was done with Eco32I (ECORV) restriction 
enzyme to generate blunt ends 
Restriction reaction 
5 µg DNA [pBluescript SK(-)] vector 
2 µl 10x buffer R (10 mM Tris-HCl, pH 8.5, 10 mM MgCl2, 100 mM KCl, 0.1 mg/ml BSA) 
1 µl Eco32I (ECORV), 10 U/µl, restriction endonuclease 
Volume was made up to 20 µl with HPLC grade H2O 
The reaction mix was incubated for 4 hours at 37°C. 
3.8.6 Ligation  
Ligation is the generation of phosphodiester bonds between neighboring 3’ hydroxyl and 5’ 
phosphate ends of double stranded DNA. This reaction is catalyzed by an enzyme, DNA 
ligase. Typically T4 DNA ligase is used for ligation reactions and it requires ATP as a 
cofactor, which is hydrolyzed to generate the phosphodiester bonds. The amount of vector 
and insert ratio for optimal ligation can be calculated with the formula: 
X ng insert = [(Y bp insert) x (50 ng vector)] / (total bp in vector) 
Ligation reaction of MBP and pBluescript SK(-) vector cut with Eco32I (ECORV) was 
carried out as given below 
Ligation reaction of 20 µl volume 
Vector-Eco32I cut blunt ended pBluescript SK(-)    1 µl 
Insert-MBP (3 µg/µl)       15 µg 
T4 DNA ligase(1 U/µl)      1 µl 
10x ligase buffer       1 µl 
HPLC grade H2O       12 µl 
The reaction was carried out at room temperature for 5 hours and the ligation mix was used 
for transformation into competent E.coli cells after the completion of the reaction. 
3.8.7 Transformation  
Transformation is a process where bacterial cells, (E. coli), take up free DNA from solution. 
Typically, bacterial cells are transformed with the ligated plasmid containing an antibiotic 
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selection marker gene, by either electroporation or through chemical transformation. During 
chemical transformation cells are heat shocked, then treated with the ligated plasmid and a 
high concentration of calcium ions. The calcium ions precipitate the DNA on the surface of 
the cell, where the DNA is forced into the recipient bacteria. This DNA then replicate by 
themselves, as extra chromosomal genomes. Transformed cells are selected by growing the 
cells in antibiotics. Only those cells containing the plasmid with the antibiotic gene are able to 
live and multiply.  
One ng of ligated DNA was mixed with 100 µl of BL-21 competent cells in an eppendorf tube 
and incubated on ice for 30 min. Heat shock was given for 75 sec at 42°C in a heating block 
and the tube was cooled for 2 min on ice. 900 µl of pre-warmed LB medium was added to the 
tube and the transformation mix was shaken for 1 hour at 37°C. 100 µl and 500 µl of bacterial 
mix were spread on separate LB-ampicillin agar plates, spread previously with X-gal/IPTG 
mix for blue white screening. 
3.8.8 Blue white colony screening 
100 µl IPTG/X-gal mix for 1 LB-ampicillin plate 
3 µl 1M IPTG 
16 µl 40 mg/ml X-Gal 
81 µl H2O 
The IPTG/X-Gal mix was spread on an LB-ampicillin plate and allowed to dry before the 
transformation mix was plated. 
3.8.9 Agarose gel electrophoresis 
Agarose gels were prepared by boiling agarose in TAE buffer, cooling the solution to 50°C 
and by adding (0.5 µg/ml) ethidium bromide, an intercalating agent of DNA. The gels were 
casted on trays with combs and DNA was loaded with (1x) L4 loading buffer and 
electrophoresis was carried out at 5-10 V/cm. As the DNA is negatively charged it migrates 
towards the positive anode and is separated based on its molecular weight (mobility is 
proportional to logarithm of molecular weight). DNA fragments of up to 1 ng concentration 
can be visualised under UV by exploiting the fluorescent properties of DNA-ethidium 
bromide complexes and their size is determined by running a DNA marker (λ/HindIII and 
λ/EcoRI/HindIII from Fermentas) alongside as standard. 
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3.8.10 Cycle sequencing 
Cycle sequencing is a reaction, where, fluorescently-labelled dideoxy nucleotides of 4 
different coloured dyes are used to label the products. As a result, the extension of the DNA is 
interrupted resulting in the formation of products of different lengths. Moreover, the reaction 
is linear and not exponential, because, only a single primer is used for the reaction. Hence, by 
loading the reaction mix into an automatic laser sequencer, the sequencer can read the 
different dyes as they pass the laser at the bottom of the gel, because the different fragments 
migrate towards the positively-charged pole at different rates, the shorter fragments migrate 
toward the bottom of the gel faster, so one can read it from bottom to top (5’->3’). The 
computer then compiles these data into the image of a gel. The colors are then read as bases to 
produce a chromatogram of the piece of DNA sequenced. The sequence can be taken right 
from the chromatogram with an extremely high level of accuracy, and the task is completed. 
Cycle sequencing reaction was done with ABI PRISM Dye Terminator Cycle Sequencing 
Ready Reaction kit from ABI (Perkin Elmer) with AmpliTaq DNA Polymerase FS. 
PCR reaction mix was prepared as given below: 
0.5-0.8 µg                        Template plasmid DNA (200 ng-1µg) 
2 µl                                  Big Dye Terminator ready reaction mix 
1 µl                                  Big Dye Sequencing buffer (5x) 
3.2 pmol                          T7 or SP6 primer 
Volume was made up to 10 µl with HPLC grade H2O 
This was followed by a PCR reaction of 25 cycles as below 
2 min                              96°C Initial denaturation 
10 sec                             96°C Denaturation 
5 sec                               50°C Annealing 
4 min                              60°C Extension 
The entire reaction was carried out in a 200 µl eppendorf tube. To precipitate the DNA for 
sequencing, 2 µl of 3M sodium acetate, pH 5.2 and 50 µl of 95% ethanol (stored at RT) was 
added to 10 µl of the above reaction mix. The mixture was vortexed briefly and centrifuged 
for 15 min, 15,000 rpm at RT. Supernatant was discarded and to the pellet, 250 µl of 70% 
ethanol (stored at RT) was added. The mixture was vortexed briefly and centrifuged for 15 
min, 15,000 rpm at RT. After centrifugation, the DNA pellet was dried in a speed vac for 3 
min or at RT for 5 min. 25 µl of HiDi Formamide was added to the dried pellet, vortexed and 
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centrifuged briefly. The DNA was denatured by heating the E-cup at 90°C for 2 min and 
cooled on ice for 5 min, vortexed and centrifuged briefly. Sequencing was done with 
ABIprism310 genetic analyzer and the sequencing data was analyzed with ABI Prism 
sequencing software. 
3.8.11 Northern blot analysis 
3.8.11.1 Isolation of RNA with TRIzol reagent 
All solutions were treated with DEPC water to inactivate RNase activity. Total RNA was 
isolated from whole brain with TRIzol reagent (Invitrogen, Karlsruhe, Germany). Brain 
samples were frozen in liquid nitrogen and TRIzol reagent was added to it (1 ml TRIzol per 
50-100 mg tissue). The samples were homogenized with a homogenizer (Ultra-turrax, Janke 
& Kunkel, Staufen, Germany) for 30 sec and incubated at RT for 5 min. 200 µl chloroform 
per 1 ml TRIzol was added and vortexed for 30 sec and incubated at RT for 3 min. After 
incubation, the samples were centrifuged at 12,000 x g for 15 min at 4°C. The supernatant 
was collected, 500 µl of isopropanol per ml of TRIzol was added and vortexed for 30 sec and 
incubated at RT for 10 min. After incubation, the samples were centrifuged for 10 min at 
12,000 x g, 4°C. The supernatant was discarded and the pellet was washed with 1 ml of 75% 
ethanol (pre-cooled at 4°C) and centrifuged at 12,000 x g for 10 min at 4°C.The pellet was air 
dried and was re-suspended in DEPC water and incubated at RT for 10 min, followed by 
incubation at 65°C for 15 min. 
3.8.11.2 Northern blotting of RNA 
20 µg of total RNA was mixed with corresponding volume of 2x RNA loading dye (MBI 
Fermentas, Germany). The samples were denatured by heating at 65°C for 10 min, incubated 
on ice for 5 min (to remove secondary structures) and were separated on a 1% denaturing 
agarose gel containing 20 mM MOPS, pH 7.0, 5 mM sodium acetate, 1 mM EDTA and 2.2 M 
formaldehyde. The separated RNA was transferred to a Hybond N+ nylon membrane 
(Amersham Pharmacia) with 20x SSC buffer. 
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3.8.11.3 Preparation of DNA templates 
Mouse PST cDNA (1.09 kb) was obtained by restriction digestion of pBluescript vector with 
HindIII/Xba1 enzymes. CST coding region was amplified by doing a PCR with CST1 sense 
and CST2 antisense primers. The products were gel purified with Qiagen gel purification kit 
and the DNA concentration was estimated by running on an agarose gel with λ HindIII 
marker as standard. 
3.8.11.4 Synthesis of [α-32P]-labelled CST/PST probes and detection of CST and PST 
mRNA 
Radiolabelled DNA probes were synthesized in an eppendorf tube by mixing 25 ng of DNA 
with 5 µl random primers. The volume was made up to 50 µl with double distilled water and 
was incubated at 95°C for 5 min and at RT for 10 min. 10 µl of labelling buffer (5x), [α-32P]-
dCTP and 2 µl of Klenow enzyme (1 U/µl) was added to the above tube and incubated at 
37°C for 10 min. Labelled probes were purified with G-50 sephadex column (Amersham 
Pharmacia) by centrifugation at 3000 rpm for 5 min (RT). 2 µl of the probe was taken in a 
scintillation vial to measure the incorporated radioactivity. The labelled DNA fragments were 
denatured at 100°C for 5 min followed by incubation on ice for 5 min. 
Membranes were pre-hybridized for 1 hour at 42°C with hybridization solution (0.2 ml 
hybridization solution per cm2 of the membrane) containing formamide, 20x SSC, 1 M Tris-
HCl, pH 7.5, 50x Denhardt´s reagent, 50% dextran sulfate, in the presence of, 100 µg of heat 
denatured salmon sperm DNA per ml of hybridization solution. Hybridization was carried out 
overnight at 42°C with 2 million cpm/ml hybridization solution of [α-32P]-dCTP labelled 
mouse CST or PST DNA. After hybridization, membranes were washed twice for 10 min at 
RT with 2x SSC, 0.1% SDS and twice for 20 min at 65°C with 0.2x SSC, 0.1% SDS. After 
washing, membranes were sealed in plastic bags and exposed to a phosphorimager screen 
(Fuji/Raytest, Straubenhardt, Germany) for a few hours at RT followed by exposure to an x-
ray film at -80°C. 
3.8.12 Generation of PLP-CST and PLP-PST transgenic constructs 
CST cDNA (1270 bp) was amplified from postnatal day 18 mouse brain by RT-PCR with 
CST1 sense and CST2 antisense primers. The PCR product was ligated into pCR4-TOPO 
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(Invitrogen) vector followed by subcloning into the EcoRI site of pcDNA3.1-zeo (Invitrogen) 
vector, resulting in the plasmid pcDNA3.1-zeo-CST (Eckhardt et al., 2002).The plasmid was 
then cut with PmeI restriction enzyme and cloned into the PLP-promoter cassette. PST cDNA 
(1095 bp) was cloned into the PmeI site of the PLP-promoter cassette (Fewou, 2005). The 
PLP-promoter cassette (a gift from W. Macklin, Cleveland Clinic Foundation, Ohio) is 
derived from PLP gene sequence. The cassette contains the PLP-promoter, transcription start 
site, exon 1, intron 1 and 37 bp of exon 2 intact.  
3.8.13 Generation of PLP-CST and PLP-PST transgenic mice 
Generation of PLP-PST transgenic mice, refer (Fewou, 2005). In order to generate PLP- CST 
transgenic mice, vector sequences were removed from the pcDNA3.1-zeo-CST plasmid by 
digesting the DNA with NotI and ApaI restriction enzymes followed by agarose gel 
purification. Pronuclear injection into fertilized eggs from F2 C57BL/6×CBA mice was 
performed at the Karolinska Center for Transgene Technologies (Stockholm, Sweden). 
Founder mice were identified by Southern blotting of StyI digested genomic tail DNA using a 
[32P]-labelled CST cDNA probe. Four transgenic founder mice were identified. Two male 
founder mice with a high transgene copy number were infertile. The other two (female) 
transgenic founder mice (tg2639 and tg2645) were bred with ASA(-/-) mice. Genotyping of 
the mice was done by PCR on genomic mouse tail DNA with CST1 sense and CST2 antisense 
primers. 
3.9 Biochemical Methods 
3.9.1 Protein precipitation (Wessel and Flügge, 1984) 
Protein precipitation was done with a mixture of chloroform:methanol:water. To 100 µl 
protein solution, taken in an eppendorf tube, 400 µl methanol was added and vortexed for 30 
sec and centrifuged for 1 min at 9000 x g (RT). To the above tube, 100 µl of chloroform was 
added. The tube was then vortexed and centrifuged as above. To the protein containing mix, 
300 µl ddH2O was added and the whole mixture containing water was vortexed for 1 min and 
centrifuged for 5 min at 9000 x g (RT). Two phases were formed and the protein is normally 
in the interphase. The upper phase was discarded without the interphase and to the remaining 
solution, 300 µl methanol was added and vortexed for 1 min and centrifuged at 9000 x g for 
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10 min (RT). After centrifugation, the supernatant was discarded, the pellet was air dried and 
was resuspended in Laemelli sample buffer (4% SDS, 0.5% bromophenol blue, 1% β-
mercaptoethanol, 0.5% glycerol, 0.5 M Tris-HCl, pH 6.8) for SDS-PAGE or stored at -20°C. 
(Depending on the initial volume of the protein solution, the entire protocol was scaled up). 
3.9.2 Protein quantification 
Protein estimation was done with BioRad Dc assay kit. This assay is based on the Lowry 
assay (Lowry et al., 1951). Five different concentrations (0.125, 0.25, 0.5, 1 and 2 mg/ml) of 
bovine serum albumin (BSA) were used as a standard for the protein estimation of the sample. 
The BSA standards were solubilized in the same buffer as the sample. The entire assay was 
carried out in a 96 well plate in triplicates of the standard, sample and negative control (5 
µl/well), pipetted into each well. 20 µl of Dc assay reagent A (20 µl of Dc assay reagent S per 
ml of reagent A). 200 µl of Dc assay reagent B was added into each well and the plate was 
incubated in dark for 5 min and then scanned with a BioRad plate reader, at 655nm. Protein 
concentration of the sample was determined in µg/µl. 
3.9.3 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
Proteins are charged due to the acidic and basic amino acids and in PAGE, the migration 
depends on the protein charge. In SDS-PAGE, proteins are separated by their molecular mass. 
Negatively charged SDS molecules bind along the polypeptide chain and confers a negative 
charge to the polypeptide chain. During electrophoresis, migration distance of the reduced 
SDS-protein complex is proportional to its molecular mass and not dependent on protein 
charge. Separating gels of different percentages and stacking gels were prepared as given 
below. 
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Reagents for SDS-PAGE separating gel 
Total volume: 10 ml 
Table 8 
 
 
Reagents for 5% SDS-PAGE stacking gel 
Table 9 
 
 
50-100 µg of the protein samples to be analyzed from brain or myelin or cell homogenates 
were denatured by heating in one fourth the volume of 4x Laemmli sample buffer. For 
detection of NCAM-PSA by Western blotting, the protein samples were denatured at 60°C for 
5 min. For detection of other proteins by Western blotting, the protein samples were 
denatured at 95°C for 5 min. After a brief centrifugation, depending on the molecular weight 
of the protein analysed, the samples were loaded onto SDS-PAGE of 7.5% or 10% or 12.5% 
gels, in an apparatus containing running buffer in both chambers. A constant voltage of 80 V 
was applied to the gel until the loading dye (bromophenol blue) entered the separating gel. 
     Ingredients                            Percentage of Gel  
      6%     7.5%     10%    12.5%      15% 
H2O   5.79 ml   5.42 ml   4.79 ml   4.17 ml   3.54 ml 
40% Acrylamide   1.50 ml   1.88 ml   2.50 ml   3.13 ml   3.75 ml 
1.5M Tris-HCl, pH 8.8   2.50 ml   2.50 ml   2.50 ml   2.50 ml   2.50 ml 
10% SDS   0.10 ml   0.10 ml   0.10 ml   0.10 ml   0.10 ml 
10% APS   0.10 ml   0.10ml   0.10 ml   0.10 ml   0.10 ml 
TEMED   0.01 ml   0.01 ml   0.01 ml   0.01 ml   0.01 ml 
Ingredients Volume for 10 ml 
H2O            6.04 ml 
40% Acrylamide            1.25 ml 
0.5 M Tris-HCl, pH 6.8            2.50 ml 
10% SDS            0.10 ml 
10% APS            0.10 ml 
TEMED            0.01 ml 
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Then the voltage was increased to 120 V until the dye reached the bottom of the gel and 
proteins were then blotted onto nitrocellulose membranes. 
3.9.4 Silver Staining  
Silver staining is the most sensitive method for permanent visible staining of proteins in 
polyacrylamide gels. This sensitivity, however, comes at the expense of high susceptibility to 
interference from a number of factors. Precise timing, high-quality reagents and cleanliness 
are essential for reproducible and high-quality results. In silver staining, the gel is 
impregnated with soluble silver ions and developed by treatment with formaldehyde, which 
reduces silver ions to form an insoluble brown precipitate of metallic silver. This reduction is 
promoted by protein. 
Fixing solution I     
30% ethanol      
10% acetic acid     
60% ddH2O      
Fixing solution II 
30% ethanol  
0.5 M sodium acetate 
0.2% sodium thiosulfate 
100% with ddH2O 
Staining solution 
0.1% silver nitrate (from 30% stock) 
Developing solution 
2.5% sodium carbonate in ddH2O and 2.5% sodium carbonate in 0.15% of 37% formaldehyde 
in ddH2O 
Neutralising solution 
5% and 1% acetic acid in ddH2O 
Procedure 
The gel was transferred to fixing solution I and was left overnight or for a minimum of 20 min 
and replaced with fixing solution II for 20 min, washed thrice with ddH2O. The gel was then 
stained for 20 min with silver nitrate solution and washed once with ddH2O for 2 min and 
rinsed with 2.5% sodium carbonate. The gel was developed with sodium carbonate-
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formaldehyde mix and the reaction was stopped with 5% acetic acid. The gel was left in 1% 
acetic acid with 0.05% glycerol. Finally, the gel was placed o/n in water containing 0.05% 
glycerol mix before drying. 
3.9.5 Western Blotting 
Mouse brains were homogenised with a homogeniser in TBS buffer, pH 7, with protease 
inhibitors and 2 mM EDTA. The crude homogenate was lysed with 1% Triton X-100 for 30 
min on ice and then centrifuged at 15,000 x g, 4°C, 15 min. Protein estimation was done with 
the BioRad Dc assay kit and 50-100 µg protein was loaded on an SDS-PAGE of different 
percentages (7.5-12.5%). The proteins were transferred onto a nitrocellulose membrane (pore 
size-0.45 µm; Schleicher & Schuell, Dassell, Germany) in a semi-dry blotting apparatus at a 
constant current of 0.8 mA/cm2 of membrane. After blotting, the membrane was stained with 
Ponceau S (Roth, Karlsruhe, Germany) (to ensure the homogeneous transfer of proteins onto 
the membrane) and washed with TBS buffer. Non specific binding sites were blocked by 
incubating the membrane with 3% skimmed milk powder in TBS containing 0.05% tween-20 
(TBS-T) for 1 hour at RT or o/n at 4°C. After blocking, the membrane was incubated with 
primary antibody diluted in blocking solution for 1 hour at RT and washed thrice with TBS-T 
for 10 min each at RT, to remove any unbound antibodies. The membrane was then incubated 
with corresponding secondary antibody, diluted in blocking solution for 1 hour at RT or o/n at 
4°C and washed thrice with TBS-T for 10 min each at RT. Bound antibodies were visualised 
with ECL system (Amersham Pharmacia) according to the manufacturers protocol or with 
indigenous ECL system. 
3.9.6 Preparation of indigenous ECL solution for detecting peroxidase conjugated 
secondary antibodies 
Solution A: 250 mM luminol (Fluka, 09253) in DMSO (MW; 177.16) i.e., 5 g in 112 ml 
DMSO solution. This solution was stored as 2 ml aliquots at –80°C. 
Solution B: 90 mM coumaric acid (Fluka, 28200) in DMSO (MW: 164.16) i.e., 1 g in 67 ml 
DMSO solution. This solution was stored as a 1 ml aliquot in eppendorf tubes at -80°C. 
Solution C : 1 M Tris, pH 8.5. 
For 20 ml: 200 µl of solution A was added to 89 µl of solution B. To this mixture, 2 ml of 
solution C was added and the volume was made up to 20 ml with ddH2O.  
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For detecting the peroxidase conjugated antibody - 
6.1 µl of 30% hydrogen peroxide was added to 20 ml of solution C, mixed well and added to 
the membrane and incubated for 1-5 min depending on the signal intensity of the protein. 
3.9.7 Coomassie staining 
Table 10 
        Staining solution            Wash solution 1        Wash solution 2 
1% (w/v) Coomassie blue –
35051                                        
   
                     -------                    
 
                     -------                    
40% (v/v) Methanol 50% (v/v) Methanol 10% (v/v) Methanol 
10% (v/v) Acetic acid 10% (v/v) Acetic acid 10% (v/v) Acetic acid 
50% (v/v) Water 40% (v/v) Water 80% (v/v) Water 
3.9.8 Lipid analysis of total brain and sciatic nerve 
Lipids were isolated as described (Van Echten-Deckert, 2000 and Yaghootfam et al., 2005). 
Total brain or a pair of sciatic nerves were homogenized with a homogenizer (Ultraturrax, 
Janke & Kunkel, Staufen, Germany) in TBS, pH 7.4 (PLP-CST mice) or in 1:2 
chloroform:methanol (PLP-PST mice). The crude homogenate was ultra-centrifuged 
(Beckmann Coulter) at 50,000 rpm in TLA-110 rotor for 60 min. The supernatant was 
discarded and the pellet was homogenized with (1:2) chloroform:methanol (v/v). Lipids were 
extracted at 56°C for 4 h with continuous stirring. The extract was filtered through a glass 
fibre wading to remove insoluble material and the filtrate was dried under N2 gas at 54°C. The 
dried lipid was re-extracted with 1:1 chloroform/methanol (v/v), filtered and dried as above. 
After extraction, the samples were treated with 100 mM NaOH in methanol for 2 hours at 
37°C, followed by reverse phase chromatography with RP18 column. The lipid was finally re-
suspended in 1:1 chloroform:methanol (v/v). 
Lipid samples were loaded on a HPTLC silica gel 60 plates (Merck, Darmstadt, Germany) 
using an automatic TLC sampler (CAMAG, Berlin, Germany) and developed by thin layer 
chromatography (TLC) using chloroform:methanol:water (60:27:4, v/v/v, to resolve sulfatide 
and galactocerebroside lipds extracted from PLP-CST mice) or (55:45:10, v/v/v, to resolve 
the gangliosides from PLP-PST mice) as developing solvents. Lipids were visualised by 
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spraying cupric sulphate in aqueous phosphoric acid on the TLC plates, followed by 
incubation at 180°C for 7 min or for 10 min (to visualise gangliosides) (Yao J.K et al., 1985). 
Stained plates were scanned and lipids were quantified by densitometry using AIDA software 
(Raytest, Straubenhardt, Germany). 
3.9.9 Isolation and purification of PAPS synthetase 
PAPS synthetase enzyme was cloned into an expression vector. The bacterial culture grown 
overnight was pelleted down and lysed with 10 ml of lysis buffer containing 10 mM 
imidazole by incubating on ice for 1 hour. After incubation, the lysate was freeze-thawed 
thrice in liquid N2-RT, and then by thawing under warm running water. The lysate was then 
incubated on ice for 30 min followed by ultracentrifugation at 25,000 rpm for 30 min at 4°C.  
A Hi trap Ni2+chelating column was washed with 5 ml of ddH2O, 1 ml 0.1 M nickel sulphate 
and 5 ml of ddH2O. The column was equilibrated with 5 ml of binding buffer at a flow rate of 
100 ml/h. After equilibration, the supernatant was loaded onto the column. 
The flow through from the column was collected and was added onto the column again. The 
column was washed with 10 ml of binding buffer at a flow rate of 50-100 ml/h. The protein 
was eluted with 5 ml of elution buffer. The eluates were collected as 500 µl fractions and O.D 
at 280nm was measured spectrophotometrically. The fractions containing the protein were 
pooled and were concentrated by adding equal volume of 10 mM Tris-HCl (pH 7)-50% 
glycerol mix and centrifuging with Centricon spin columns at 4°C as per the manufacturers 
instructions. 
3.9.10 [35S]-PAPS-synthesis 
 [35S]-labelled 3'-phosphoadenosine-5'-phosphosulfate ([35S]-PAPS) was synthesized using 
recombinant murine PAPS synthetase and [35S]-sulfate in a reaction mixture containing 
reaction buffer (150 mM Tris-HCl, pH 8.0, 50 mM KCl, 15 mM MgCl2, 3 mM EDTA, 45 
mM DTT), 200 mM ATP, 3.25 µCi [35S]-Na2SO4, 0.5 U/µl pyrophosphatase and murine 
PAPS synthetase.  
PAPS reaction 
50 µg PAPS synthetase 
15 µl reaction buffer 
1.3 µl [35S]-Na2SO4 
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3.2 µl pyrophosphatase 
2 µl ATP 
Volume made up to 100µl with ddH2O 
The reaction was carried out at 37°C for 3 hours and stopped by incubating the reaction mix 
at 95°C for 5 min, followed by centrifugation at 14,000 x g for 5 min at RT. The radiolabelled 
PAPS was loaded on a PEI TLC plate (Merck, Germany). [35S]-labelled sulfate was loaded as 
a control. The plate was developed with 0.9 M LiCl and visualised with a phosphorimager 
screen. The incorporation of radiolabel was calculated with a scintillation counter. 
3.9.11 Cerebroside Sulfotransferase Assay 
Whole brain from PLP-CST transgenic and wild-type mice were dissected and briefly 
homogenized in TBS containing 100 mM PMSF and 20 µg/ml aprotinin. The homogenates 
were adjusted to a protein concentration of 10 mg/ml. Initially, GalC (4 mg/ml) and 1% 
Triton X-100 were dried in an eppendorf tube. The assay was started by addition of 10 µl of 
the homogenate to 40 µl reaction mixture containing 100 mM Tris-HCl (pH 7.0), 20 mM 
MgCl2, 2.5 mM ATP and 50 µM [35S]-PAPS (~3.7 MBq/µmol) and incubation at 37°C for 2 
hours. After incubation, the reaction was stopped by adding 1 ml of chloroform:methanol 
(2:1, v/v) and 200µl of 150mM NaCl. The mixture was vortexed and centrifuged at 14,000 x 
g for 5 min at RT. The organic phase was collected and was washed once with methanol:150 
mM NaCl:chloroform (48:47:3, v/v/v) and dried in a speed vac concentrator (Savant). The 
dried samples were re-suspended in 20 µl chloroform:methanol (2:1, v/v), loaded on a silica 
gel 60 HPTLC plate (Merck, Germany) and developed with chloroform:methanol:H2O 
(65:25:4, v/v/v) as solvent system. The radioactive sulfatide was visualised with a 
phosphoimager screen (Raytest, Straubenhardt, Germany) and quantified using AIDA 
software (Raytest). For quantification, the AIDA values obtained with AIDA software were 
subtracted from the background and this value, AIDA value-background, was then expressed 
as arbitrary units for each of the sample. These arbitrary units were then used as a measure to 
express the CST activity of each sample. 
3.9.12 Myelin preparation 
All solutions used for the preparation contained 1 mM PMSF, 20 µg/ml aprotinin as protease 
inhibitors and the entire preparation was carried out at 4°C. All centrifuge tubes and rotors 
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were pre-cooled. The principle of the method relies on the low density of myelin compared to 
other cellular membranes due to its high lipid content. Hence, myelin can be isolated as a 
band between 5% and 30% sucrose. The contaminating axonal membrane (axolemma) can be 
removed by several osmotic shocks and sucrose gradient. 
Myelin was isolated from forebrains of 2-month-old transgenic and wild-type mice, at 
different time points as described (Norton and Poduslo, 1973). Briefly, brains were 
homogenised in 8 ml 10.5% (w/v) sucrose-water using an Ultra-turrax homogenizer and 
centrifuged at 17,000 x g for 45 min at 4°C. The supernatant was discarded and the pellet was 
re-suspended in 9 ml 30% (w/v) sucrose-water and transferred to a 12 ml ultracentrifuge tube. 
The myelin-30% sucrose solution was overlaid with 3 ml 5% (w/v) sucrose-water and 
centrifuged at 68,000 x g for 50 min at 4°C. Myelin was recovered carefully from the 30% / 
5% inter-phase into a new tube and was subjected to hypo-osmotic shock by washing twice 
with water and centrifugation at 68,000 x g for 50 min at 4°C, followed by a second sucrose 
gradient (30%-5%) and centrifugation at 68,000 x g for 50 min at 4°C. The purified myelin 
was again washed twice with water and was re-suspended in water and stored in aliquots at -
80°C. 
In order to determine the total amount of myelin in the brain, the purified myelin was 
lyophilized and the dry weight was determined. For protein assays and Western blotting, 
myelin samples were solubilized in 1% SDS. Protein concentrations were determined using 
the BioRad DC protein assay (BioRad, München, Germany). 
3.9.13 Preparation of detergent resistant membrane fractions 
Detergent (Triton X-100) resistant myelin membranes (DRM) were isolated as described 
(Krämer et al., 1999). Briefly, myelin (500 µg protein) of total brain was solubilized in TNE 
(10 mM Tris-HCl, pH 7.4, 150 mM NaCl, pH 7.4, 5 mM EDTA, 1 mM PMSF) with 2 % 
Triton X-100. The extract was incubated on ice for 30 min with vortexing every 5 min. One 
volume of 80% sucrose (in TNE) was added, overlaid with a step gradient of 30% and 5% 
sucrose (in TNE). The sucrose gradient was centrifuged at 35,000 rpm with a Beckman SW41 
rotor for 16 h at 4°C. One ml fractions of the sucrose gradient were recovered from the top of 
the gradient. 
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3.10 Cell Culture 
3.10.1 Preparation of mixed glial cell culture from brain 
Newborn mice were genotyped and cultures from transgenic and wild-type mice were 
prepared separately. Mixed cultures were prepared from the forebrains of postnatal day 1 or 2 
mice. The cerebral hemispheres were removed and transferred to cold Hank’s balanced salt 
solution (HBSS) and were cut into small pieces. Finely cut tissue was dissociated in 1% 
trypsin (Sigma) for 12 min at room temperature. The tissue homogenate was mixed with 7 ml 
HBSS (Sigma) and centrifuged at 600 x g for 10 min at 4°C. The supernatant was removed 
and the pellet was further dissociated with addition of 0.05% DNase (Sigma, bovine pancreas) 
solution. Flamed Pasteur pipettes (first with a large (1 mm), then with a medium (0.5 mm) 
and finally with a small opening) were used, to pipette repeatedly, to remove any clumps. The 
dissociated cells were washed with HBSS as describe above. The pellet was re-suspended in 
DMEM containing 10% horse serum, 2 mM Glutamine, 100 U/ml penicillin and 100 U/ml 
streptomycin. Finally the cells were seeded in poly-L-lysine (sigma, MW >300,000) coated 
tissue culture flask and maintained in the same medium (DMEM + 10% horse serum) 
described above for 8-10 days in a humidified incubator at 37°C, in the presence of 5% CO2. 
3.10.2 Preparation of primary oligodendrocyte cell culture 
Primary oligodendrocyte cultures are prepared from confluent glial cultures. After 8 to 10 
days, when glial cell culture reached confluence, microglial cells were dislodged by tapping 
the culture flask 3-4 times and the medium was removed and the flask was washed once with 
10 ml cold HBSS, followed by addition of fresh cold medium (DMEM containing 5% horse 
serum). Oligodendrocyte precursor cells grown on top of the astrocytes monolayer were 
shaken off by harsh shaking for 20-30 sec. The medium was collected and the cells were 
centrifuged at 600 x g for 5 min at RT. The supernatant was removed and the pellet was re-
suspended in DMEM containing 5% horse serum. The cells were seeded on a Petri dish for 30 
min, to allow the remaining microglia to attach to the dish. The non-adherent 
oligodendrocytes containing medium was collected and centrifuged at 600 x g for 5 min at 
RT. The pellet was re-suspended in SATO medium (DMEM supplemented with 10 µg/ml 
insulin, 0.1 mM putrescine, 0.2 µM progesterone, 0.5 µM triiodothyronine, 0.22 µM sodium 
selenite, 0.1 mg/ml apo-transferrin, 520 nM L-thyroxine, 25 µg/ml gentamycin, 2 mM L-
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glutamine, 100 µg/ml penicillin, 100µg/ml streptomycin) with 1% horse serum and the cells 
were seeded on poly-L-lysine coated glass cover slips at a density of 3-4×104 cells/12 mm 
cover slip and grown in SATO medium. 
3.10.3 Immunofluorescence of primary oligodendrocyte culture 
Cover slips containing primary oligodendrocytes were collected at different days (day1 to day 
4), were fixed in 4% paraformaldehyde in PBS for 10 min at room temperature. Non-specific 
binding sites were blocked for 30 min in 0.2% gelatin in PBS and cells were permeabilized 
with 0.3% Triton X-100. Cells were incubated with rabbit anti-MBP antibody (1:200), diluted 
in 0.2% gelatin in PBS. In some experiments, cells were additionally stained for PSA using 
mouse monoclonal antibody 735 (1:50 of 1 mg/ml) ((Frosch et al., 1985), rabbit anti L-MAG 
(1:100) (kind gift from, A. Butt), rat monoclonal antibody H28 NCAM (hybridoma cell 
culture supernatant) and rat monoclonal IgM ENCAM (1:100). Primary antibodies were 
detected with anti-rat IgM-Alexa Fluor 594 (1:200), anti-rabbit Ig- Alexa Fluor 488 (1:400) 
(Molecular probes), anti-rabbit Ig-Cy2 (1:200), anti-rabbit Ig-Cy3 (1:400), anti-mouse Ig-Cy3 
(1:400) and anti-rat Ig-Cy2 (1:400) (Jackson Immunoresearch / Dianova, Hamburg, Germany) 
in blocking solution. Nuclei were stained with DAPI. Specimens were mounted in Kaiser's 
gelatin and analyzed with an Axiovert 100M microscope (Carl Zeiss, Jena, Germany). 
3.11 Immunohistochemistry 
3.11.1 Immunofluorescence of brain and optic nerve cryosections 
Whole brains and eye with optic nerves of PLP-PST transgenic and wild-type mice were 
removed, immediately frozen in cold isopentane and stored at -80°C. Coronal or sagittal 
cryosections were cut at 10 µm thickness on a cryostat at -20°C by mounting the tissue with 
Tissue-Tek OCT (Sakura Finetek, Europe) and post fixed in 4% paraformaldehyde in PBS for 
10 min at RT. Cryosections were stored with desiccant at -80°C. Sections were permeabilized 
with 0.3% Triton X-100 and non-specific binding sites were blocked with 1% BSA,  5% FCS, 
in PBS for 1 hour at RT. PSA and MBP were stained with antibodies 735 (Frosch et al., 1985; 
mouse IgG; gift of Rita Gerardy-Schahn, Medizinische Hochschule Hannover, Germany) 
(1:500) and rabbit MBP antiserum (Chemicon, Hofheim, Germany) (1:200) in blocking 
solution. Primary antibodies were visualized with anti-mouse Ig-Cy2 (1:200) and anti-rabbit 
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Ig-Cy3 (1:300) conjugate in blocking solution. Nuclei were counter stained with DAPI. 
Sections were mounted in Kaiser’s gelatin (Merck, Darmstadt, Germany) and examined with 
a Zeiss Axiovert fluorescence inverted microscope attached to an Axiocam camera. 
Photographs were taken with the Axiovision program (Carl Zeiss, Jena, Germany). 
3.11.2 Cryoprotection of brain tissue 
Mice were perfused with 5 ml PBS followed by 50 ml 4% PFA-PBS. The brains are dissected 
out from the animal and post fixed o/n in 4% PFA, followed by incubation in 5% sucrose-
PBS for 1 hour, 15% sucrose-PBS for 5 hours (or until the brain sinks to the bottom), 20% 
sucrose, o/n. The tissue was then removed and immersed into cold isopentane kept on dry ice 
for 5 sec and put into a pre-cooled tube and stored at -80°C until further use. 
3.11.3 In situ Hybridisation 
In situ hybridisation was performed either on paraffin sections or on cryosections (10 µm 
thickness). For cryosections, total brain was dissected from mice and was immersed into cold 
isopentane, kept on dry ice, before transferring the tissue to -80°C. 
3.11.3.1 Preparation of probe 
cRNA probes for MAG was synthesised from cDNA (1997 bp) cloned into pCR Blunt II 
TOPO vector (clone ID IRAM p995E019Q obtained from RZPD, Berlin, Germany). MBP 
cRNA probes were prepared from mouse brain RNA, by reverse transcribing the RNA and 
amplifying the cDNA with MBP sense and antisense primers. The above MBP PCR product  
(2032 bp) was run on a 1% agarose gel and the band corresponding to the size of MBP was 
cut and purified with Qiagen gel purification kit, according to the instruction of the 
manufacturer and was cloned into pBluescript SK(-) vector (Stratagene) by blunt end ligation 
with Eco32I. Positive colonies were selected and plasmid DNA was isolated with Qiagen 
plasmid purification kit. MAG/MBP antisense and sense probes were transcribed with T7 or 
SP6 RNA polymerase and digoxigenin-RNA labelling kit according to the instruction of the 
manufacturer (Roche Molecular Diagnostics, Mannheim, Germany). 
1 µg linearised plasmid 
2 µl Digoxigenin-RNA labelling mix 
2µl 10x Transcription buffer 
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2 µl RNA Polymerase (T7 or SP6) 
The volume is made up to 20 µl with DEPC H2O  
The reaction mix was mixed, centrifuged briefly and incubated for 3 hours at 37°C. Template 
DNA was removed with 2 U RNase free DNaseI (10 U/µl, Roche, Germany) and incubation 
at 37°C for 15 min. After incubation, 0.8 µl of 0.5 M RNase free EDTA and 1.2 µl DEPC 
water was added to stop the reaction. 1/10th volume of 3 M sodium acetate and 2 volume cold 
100% ethanol was added to the cRNA’s and precipitated o/n at -80°C, followed by 
centrifugation at 15,000 rpm, 60 min, 4°C. The pellet was washed once with cold 70% 
ethanol, air-dried and re-suspended in 24 µl DEPC H2O. 
3.11.3.2 Determination of cRNA probe dilution 
MBP, MAG-sense and antisense cRNA probes were serially diluted (1:20, 1:200, 1:2,000, 
1:20,000 and 1:200,000) in DEPC treated water. A cRNA probe whose concentration was 
already determined was used as a control. 1 µl from each of the above dilutions from MAG, 
MBP cRNA and 1 µl of control cRNA was spotted onto a Hybond N+ nylon membrane. The 
membrane was baked for 30 min at 120°C and washed for 1 min with washing buffer and 
incubated for 30 min with blocking solution. The membrane was then incubated for 30 min 
with anti-digoxigenin antibody (1:10,000) diluted in blocking solution, washed twice for 15 
min each with washing buffer to remove any unbound antibody and then incubated for 2 min 
in AP buffer. The membrane was developed o/n with NBT/BCIP in AP buffer.The dilutions 
of the digioxigenin labelled cRNA’s were determined visually by comparing the signal 
intensity of the different dilutions with the control cRNA. 
3.11.3.3 Preparation of tissue 
In situ hybridisation was carried out as described by Baader et al. (1998). Paraffin sections 
were dehydrated by immersing in xylol thrice for 10 minutes each followed by immersion in 
100% propanol, thrice, 5 min each. The sections were rehydrated by immersing in 96% 
propanol, 90% propanol and in 75% propanol once, 5 min each and then in 50% propanol for 
2 min and washed for 5 min once with PBS-DEPC. The sections were fixed with 4% PFA for 
90 min (cryosections were thawed at room temperature for 30 min before fixation). After 
fixation, the slides were washed twice with PBS-DEPC for 5 min. The sections were 
permeabilized with Proteinase K for 4 min, followed by washing for 5 min once with PBS- 
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DEPC. A second permeabilization with 0.25% Triton X-100 was performed for 4 min 
followed by washing 3 times with PBS-DEPC. The sections were incubated in 0.2 M HCl for 
8 min, in 0.1 M TEA for 10 min and then in 2x SSC at 50°C for 10 min. 
3.11.3.4 Hybridization 
Hybridization was performed with digoxigenin-labelled sense and antisense cRNA riboprobes 
for MAG and MBP in hybridization buffer (50% formamide, 1x Denhardt’s solution, 0.1% 
SDS, 0.25 mg/ml ssDNA, 10% dextran sulphate and 10% hybridization salt solution (3 M 
NaCl, 0.1 M PIPES, 0.1 M EDTA) and 4 M DTT. The digoxigenin-labelled cRNA’s were 
diluted in 1x SSC-DEPC 
Dilutions of digoxigenin-labelled cRNA’s 
MBP sense-1: 200   MAG sense-1: 200 
MBP antisense-1: 600  MAG antisense-1: 200 
The probes were heated for 5 min at 80°C, cooled on ice for 5 min and incubated with the 
sections o/n at 70°C in a humid chamber (the sections containing the probe were covered with 
GeneFrame (Abgene, Surrey, UK)). After incubation, to remove any unbound and non-
specific probes, the sections were washed with 2x SSC, 5min, 60°C; 2x SSC, 30 min, 60°C; 
50% formamide in 1x SSC, 20 min, 60°C; 0.1x SSC, 45 min, 70°C. 
3.11.3.5 Detection 
The sections were incubated with MAB buffer (100 mM Maleic acid, pH 7.5; 150 mM NaCl) 
for 5 min at RT. Non specific binding sites were blocked with 10% blocking reagent (Roche 
Diagnostic GmbH, Germany) in MAB buffer for 1 hour at RT and incubated o/n with anti- 
digoxigenin alkaline phosphatase (AP) Fab-Fragment antibody (1:5,000 dilution, Roche 
Diagnostic GmbH, Germany) at 4°C in a humid chamber. Excess antibody was removed by 
washing with MAB buffer, five times, 1 hour each and then with AP buffer (100 mM Tris-
HCl, pH 9.5; 100 mM NaCl, 50 mM MgCl2) for 5 min, RT. Detection was done by incubating 
in the dark with 200 µl NBT/BCIP (Roche Diagnostic GmbH, Germany)/10 ml AP buffer at 
RT. For MBP and MAG mRNA detection, incubation was done for 5 hours and 16 hours, 
respectively. 
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Stained sections were washed with ddH2O and mounted using Kaiser’s gelatin. Number of 
positive cells from wild-type and PLP-PST transgenic mice were counted and difference of 
means was tested with Student’s t- test. 
3.12 Apoptosis assay (TUNEL assay) 
Parasagittal cryosections of brains from 14-day-old transgenic PLP-PST and wild-type mice 
were used for performing an apoptosis assay. The assay was carried out with BrdUTP-
FragELTM DNA Fragmentation Detection kit (Merck Biosciences, Darmstadt, Germany), as 
per the manufacturers instruction. This assay is based on the principle that TdT binds to the 
free 3’-OH group of fragmented DNA generated in apoptotic cells and catalyzes the addition 
of biotin labelled and unlabelled deoxynucleotides. Biotinylated nucleotides are detected 
using a streptavidin-horseradish peroxidase conjugate and addition of diaminobenzidine 
(DAB) results in the formation of an insoluble coloured substrate at the site of DNA 
fragmentation. The cryosections were fixed in 4% PFA and permeabilized with 20 µg/ml 
proteinase K. Endogenous peroxidases were inactivated with 30% H2O2 diluted in methanol. 
The labelling reaction was carried out with BrdU labelled dUTPs and TdT enzyme. The 
enzymatic reaction was detected using anti BrdU-biotin/streptavidin conjugate and DAB as 
substrate. 
3.13 Preparation and immunofluorescence staining of teased sciatic nerve fibres 
PLP-CST mice were sacrificed and sciatic nerves were collected from the hind limbs and 
transferred to cold PBS on ice. The sciatic nerve was transferred to a super frost glass slide 
and with a very fine forceps one end of the nerve was held and single nerve fibres (teased 
fibres) were obtained by pulling the other end of the sciatic nerve with another fine forceps. 
The teased fibres were air dried overnight at room temperature. After drying, the slides were 
used immediately for immunostaining or stored at -80°C until further use. 
The slides were thawed at room temperature (if stored at –80°C) and bordered with PAPPEN. 
The teased fibres were fixed by adding ice-cold acetone for 10 min at RT and washed twice 
with PBS for 10 min each at RT. The fibres were permeabilized with 0.5% Triton X-100 and 
washed thrice with PBS, 10 min each at RT. Non specific binding sites were blocked with 5% 
FCS/1% BSA in PBS for 30 min at RT. Na+ channel and paranodin stainings were done with 
mouse anti-sodium channel PAN and rabbit anti-paranodin antibodies in blocking solution for 
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1 hour at RT. Unbound primary antibodies were washed thrice with PBS, 10 min each (RT). 
Primary antibodies were detected with anti-mouse Ig-Cy2 and anti-rabbit Ig-Cy3 antibodies. 
Unbound secondary antibodies were washed twice with PBS, 10 min each (RT). Nuclear 
staining was done by incubating the preparation for 1 min at RT with PBS-DAPI (1:500) 
(Sigma). The stained fibres were mounted using 50% glycerol in 1x PBS and Kaiser‘s gelatin 
bordering the cover slips. 
3.14 Rotarod assay  
Rotarod assay is a motor activity analysis, which tests for balance and co-ordination in mice. 
The mice are placed on a rotating rod and the cumulative falls/minute or the time the mouse 
remained on the rod is calculated. The assay was done as described (Kuhn et al., 1995) with 
modifications. The mice were acclimatized with the rotarod for 3 days by placing them on the 
rotating rod (3 rpm) for 10 sec. On the fourth day, mice were tested for 1 min at 3 rpm [5-11 
months old mice; number of mice tested - 8 tg/ASA(-/-) and 8 ASA(-/-)] or 1.3 rpm [21-24 
months old mice; number of mice tested - 10 tg/ASA(-/-), 8 ASA(-/-), 10 tg (ASA(+/-), 6 
wt/ASA(+/-)] and the number of falls / min was recorded. The cumulative number of falls per 
min was calculated and differences of means were tested for statistical significance using 
Student’s t-test. 
3.15 Electrophysiological investigations 
Electrophysiological investigations were performed by Dr. Carsten Wessig (University of 
Würzburg) as described previously (Zielasek et al., 1996). Motor nerve conduction of sciatic 
nerves and EMG of intrinsic foot muscles were studied in anaesthesia. In brief, CMAP was 
recorded with two needle electrodes in the foot muscles after distal stimulation of the tibial 
nerve at the ankle and proximal stimulation of the sciatic nerve at the sciatic notch. EMG of 
foot muscles was assessed for spontaneous activity. Statistical analysis was performed using 
Student's t-test. 
3.16 Preparation of avertin (anaesthetic) 
40x stock of avertin -1 g, 2, 2, 2-tribromoethanol (Fluka) in 1 ml tertiary amyl alcohol 
(Fluka). Dilute to 2.5% avertin (100 µl 40x stock + 3.9 ml 0.9 % NaCl). 
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3.17 Perfusion of mice 
Mice were anaesthetised by injecting intra-peritoneally with 700-800 µl of 2.5% avertin 
solution. The abdominal region of mice was cut in the form of a ‘T’ from middle abdomen to 
cervix and at the caudal edges to both sides. The peritoneum below the lower thoracic 
aperture, diaphragm and thoracic cage were opened. Mice were then perfused by cutting the 
right atrium and then by inserting a sharp needle (26G X ½’’) into the left ventricle, first with 
warm (37°C) 100 mM phosphate buffer [100mM potassium dihydrogen phosphate (K2HPO4) 
and 100mM disodium hydrogen phosophate (Na2HPO4)] for 15 min and then with warm 
(37°C) 6% glutaraldehyde in 100 mM phosphate buffer for 30 min. The fixed animals were 
post fixed in 3% glutaraldeyde in 100 mM phosphate buffer and stored at 4°C until further 
use. 
3.18 Electron microscopy and alcian blue staining 
Electron microscopy and alcian blue stainings were performed by Prof. Renate Lüllmann-
Rauch & Kerstin Khalaj Hedayati (University of Kiel). 7-months and 18-months-old PLP-
CST mice were anaesthetised and perfused intracardially with 6% glutaraldehyde or 25% 
Bouin’s solution. Alcian blue staining of vibratome sections, toluidine blue staining of semi-
thin sections and electron microscopy of ultra-thin sections were done as described recently 
(Wittke et al., 2004). 
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4. Results 
4.1 Analysis of PLP-PST transgenic mice 
As the oligodendrocytes undergo differentiation, the expression of PST is downregulated in 
adult mice, resulting in the downregulation of polysialylated NCAM. In order to understand 
how PSA downregulation is important for oligodendrocyte differentiation and myelin 
formation, transgenic mice was generated by overexpressing PST under the control of PLP 
promoter, so that these mice sustain polysialylation and do not downregulate PSA on NCAM 
in oligodendrocytes.  
4.1.1 Generation of PLP-PST transgenic mice 
The transgenic construct was generated by ligating the 1.08 kb murine PST cDNA into the 
PmeI site of the PLP promoter cassette (gift from Dr.Wendy Macklin). The PLP promoter 
cassette consists of the 5’-flanking region containing the PLP promoter, first exon, first intron 
and the splice acceptor site of exon 2 of the mouse PLP gene. The ATG start codon in the 
cassette was mutated; so that, translation would take place from the start codon of the cDNA 
construct (Fig. 4A). Several transgenic mice were generated and identified by Southern 
blotting of mouse tail genomic DNA which was digested with AccI restriction enzyme. PST 
cDNA was used as a probe to identify the transgene. Of the several transgenic mice identified, 
two transgenic mice lines, tg281 and tg246 were established and maintained on a mixed 
C57BL/6×CBA genetic background. tg246 line carried a higher copy number of the transgene 
in their genome when compared to the tg281 line. Generation and identification of the 
transgenic mice by southern blotting were done by Dr. Simon Fewou (Fewou, 2005). 
4.1.2 Expression level of PST mRNA 
The expression level of both endogenous and transgenic PST mRNA was investigated by 
performing a Northern blot analysis (Fig. 4B). Total RNA from transgenic and wild-type litter 
mates, postnatal day 1 (P1) and 7-months-old mice, was isolated, blotted onto a Hybond N+ 
nylon membrane and detected with [α-32P]-dCTP labelled PST specific cDNA probe. The 
transgene mRNA expression was upregulated in the transgenic animals between P1 and 7-
months and the endogenous mRNA expression was downregulated in the wild-type animals. 
Transgene expression in the tg246 line was higher than the tg281 line. To get a signal of the 
endogenous PST mRNA in adult wild-type and transgenic animals, the membrane was 
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overexposed. As a result of this overexposure, the endogenous PST mRNA signal in the 7-
months-old mice from tg246 line is not clearly visible. 
 
Figure 4: PLP-PST transgenic construct and Northern Blot analysis of PST mRNA expression. (A) 
Represents a schematic diagram of the PLP-PST transgenic construct (Fewou, 2005). (B) PST mRNA expression 
of postnatal day 1 (P1) and 7-months-old wt and tg mice from lines, tg246 and tg281, were analysed by Northern 
blot analysis. 10 µg/lane of total RNA from brain was separated on an agarose-formaldehyde gel and transferred 
to a Hybond N+ nylon membrane and detected with PST specific probe. The wild-type and transgenic PST 
mRNA were detected and their molecular weights (transgene - 1.08 kb; endogenous - 5.4 kb) are indicated in the 
figure. 7-months-old mice had a stronger transgene expression than 1-day-old mice. Transgene expression in 
tg246 line was higher than the tg281 line. Ethidium bromide staining was used to control for equal loading of 
lanes. 
4.1.3 PSA is expressed in the white matter of PST transgenic mice  
PSA expression in 4-months-old adult transgenic mice was examined by immunofluorescence 
staining of sagittal and coronal cryosections of brain and optic nerve, respectively. Double 
staining of cryosections was carried out with MBP and PSA antibodies. In the brain of wild-
type mice, PSA expression was restricted to the subventricular zone around the lateral 
ventricles and no expression was detected in the white matter regions of corpus callosum (Fig. 
5A), cerebellum [Fig. 6A (b)] or optic nerve (Fig. 7A). In contrast, in the transgenic mice, 
PSA was strongly expressed in the white matter tracts of corpus callosum (Fig. 5E), 
cerebellum [Fig. 6A (e)] and optic nerve (Fig. 7E, I). Double staining with PSA and MBP 
antibodies showed co-localization of PSA with MBP indicating the presence of PSA in 
myelin [Fig. 6A (f)]. Higher magnification of microscopic pictures of cerebellum, indicated 
only partial co-localization of PSA with MBP [Fig. 6B(c)]. The wild-type animals showed no 
co-localization of PSA with MBP [Fig. 6A (c) and 7D]. 
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Figure 5: Immunofluorescence staining of parasagittal brain cryosections from PLP-PST mice. Parasagittal 
cryosections of brain from 4-months-old wt and tg mice were prepared and immunofluorescence double staining 
with PSA and MBP antibodies was carried out. (A, B, C & D) are stainings of wt brain and (E, F, G & H) are of 
tg brain. Nuclear staining was done with DAPI (C & G). In the tg brain LV-lateral ventricle and CC-corpus 
callosum, stained strongly for PSA when compared to the wt mice, where staining was restricted to the 
subventricular zone with no staining in corpus callosum. (D & H) merged pictures of PSA and MBP stainings. 
Scale bar 100µm (A-H). 
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Figure 6: PSA expression in cerebellum of PLP-PST mice. Parasagittal cryosections of brain from 4-months-
old tg and wt mice were cut and stained for PSA and MBP.  (A) Lower magnification of the cerebellar tracts 
from wt (a, b & c) and tg (d, e & f) mice for MBP (a & d); PSA (b & e) and merged (c & f) stainings. (B) Higher 
magnification pictures of cerebellum from transgenic mice stained for MBP (a), PSA (b) and merged (c) taken 
with an Axiovert mcroscope, showing partial co-localization of PSA and MBP in cerebellum. Scale bars: 50 µm 
[A (a-f)] and 10 µm [B (a-c)]. 
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Figure 7: PSA expression in optic nerve of PLP-PST mice. Coronal cryosections of optic nerve from 4-
months-old tg and wt mice were cut and stained for PSA and MBP. (A, B, C & D)-wt; (E, F, G & H)-tg mice 
from tg246 line; (I, J, K & L)-tg mice from tg281 line. (A, E & I)-PSA staining; (B, F & J)-MBP staining. 
Nuclear staining was done with DAPI (C, G & K); (D, H & L) are merged pictures of PSA and MBP stainings. 
on-optic nerve. Scale bar: 50µm (A-L). 
4.1.4 Overexpression of PST leads to a decrease in the number of mature 
oligodendrocytes 
The transgenic overexpression of PST leads to a decrease in myelin content and MBP gene 
expression (Fewou, 2005). These results led to the hypothesis that the decrease in myelin and 
MBP level could be due to several possibilities namely (a) decrease in the number of 
oligodendrocyte precursor cells (b) decrease in the number of mature differentiated 
oligodendrocytes (c) apoptosis of mature oligodendrocytes or (d) reduced synthesis of myelin. 
Hence, to understand and verify which of the hypothesis is valid, an in situ hybridization was 
performed on parasagittal cryosections of brains from 1-week-old transgenic and wild-type 
littermates, with digoxigenin-labelled PDGF α-receptor, (PDGF α-receptor is a marker for 
oligodendrocyte precursor cells), PLP (Fewou, 2005), MAG and MBP (Fig. 8A) (markers for 
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differentiated oligodendrocytes) cRNA probes. Counting the number of PDGF α-receptor 
positive cells in the forebrain by Dr. Simon Fewou did not show any significant difference in 
the cell number between transgenic and wild-type mice. However quantification of PLP 
positive cells showed a significant decrease in the transgenic mice when compared to wild-
type mice (Fewou, 2005). Since PLP is also expressed in a subpopulation of OPCs the 
reduction that was observed could be due to a reduction in this subpopulation of OPCs or 
could be a general reduction in differentiated oligodendrocytes. Hence, to verify this, the 
number of mature oligodendrocytes was quantified by counting the number of MAG positive 
cells in the forebrain regions (corpus callosum) of both transgenic and wild-type animals (Fig. 
8B). Counting the number of MAG positive cells also indicated a reduction in the number of 
cells in transgenic mice when compared to wild-type animals, which points towards a 
decrease in differentiated oligodendrocytes upon PST overexpression. For quantification, 
MBP positive cells were not considered, as MBP is expressed even in the branches of 
differentiated oligodendrocytes, distinguishing the cell body from the branches of fully 
differentiated oligodendrocytes is difficult. 
 
Figure 8: In situ hybridisation of 1 week old PLP-PST mice brain. In situ hybridization was performed on 
cryosections of brain from 1-week-old wild-type and PLP-PST transgenic mice (tg246 line). In situ hybridization 
was done with DIG-labelled cRNA probes for MBP and MAG. n=3 animals per genotype were used for the 
analysis. (A) MBP and MAG positive cells from the corpus callosum region of the brain were documented. (B) 
Number of MAG positive cells was counted for both transgenic and wild-type animals and the percentage of 
MAG positive cells was calculated. Shown are the mean ± SD (n=3). (* p<0.05 determined by Student’s t-test). 
Scale bar: 100µm (A). 
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4.1.5 Effect of transgenic over expression on oligodendrocyte cell death 
In order to rule out that the decrease in mature oligodendrocyte number is due to apoptosis of 
oligodendrocytes, a TUNEL assay was carried out on the coronal cryosections from 14-days-
old transgenic (Fig. 9B & C) and wild-type (Fig. 9A) mice. After staining, the sections were 
evaluated under a microscope. Few TUNEL positive cells were detected in both transgenic 
and wild-type mice; otherwise, there was no significant difference in the TUNEL staining 
between the transgenic and wild-type mice. 
 
Figure 9: TUNEL assay to detect apoptosis in PLP-PST mice. TUNEL staining of parasagittal cryosections 
from forebrain of 14-days-old mice from wt-wild-type, tg246-transgenic tg246 line and tg281-transgenic tg281 
line. A few TUNEL positive cells (indicated by an arrow) were detected in wild-type and transgenic animals, but 
there was, however, no increase in the number of apoptotic cells in transgenic mice when compared to wild-type 
mice. Scale bar: 100µm (A-C). 
4.1.6 Overexpression of PST does not alter the ganglioside composition in transgenic 
mice  
Gangliosides are oligosialylated glycosphingolipids carrying strings of sialylated 
oligosaccharide side chains. To investigate the possibility of alterations in ganglioside 
composition due to PST overexpression, total brain lipids were isolated, alkaline hydrolyzed 
and resolved on a HPTLC plate (Fig. 10). Analysis of the different gangliosides namely, 
GM1a, GD1a, GD1b, GT1b, led to the observation that there was no significant difference in 
the ganglioside composition between transgenic and wild-type mice. 
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Figure 10: TLC analysis of gangliosides in PST transgenic mice. Effect of PST overexpression on sialylated 
gangliosides was analysed by TLC. Total brain lipids from 3-months-old tg246-transgenic line 246 and wt-wild-
type mice were separated in (55:45:10) chloroform:methanol:water, solvent system. TLC analysis was done with 
3 animals per genotype. Ganglioside mix (GM1a, GD1a, GD1b, and GT1b) and sphingomyelin from bovine 
brain were used as standards. Figure shows the lipid profile from two tg and two wt animals. 
4.1.7 In vitro culture of PST overexpressing oligodendrocytes 
To examine the influence on morphology and differentiation of oligodendrocytes due to PST 
overexpression, mixed glial cell cultures were prepared from the forebrain of newborn mice 
and maintained for 8-10 days in DMEM containing 10% horse serum. The mixed glial cell 
culture is composed of astrocytes, forming an astrocyte monolayer, microglia and 
oligodendrocyte progenitors. The microglia and oligodendrocyte progenitors, which grow on 
top of the astrocytic monolayer, were removed by shaking the flask. Oligodendrocyte 
progenitor cells are separated from microglia by incubating the oligodendrocyte 
progenitor/microglia cell mixture on a plastic Petri plate. Microglia remained attached to the 
Petri plate and the oligodendrocyte progenitors remained in the medium. These 
undifferentiated oligodendrocyte progenitors in the medium were collected and were then 
differentiated in SATO medium, containing 1% horse serum, fixed and collected for 
immunofluorescence staining with ENCAM and MBP antibodies, between 1 and 4 days of 
culture (Fig. 11 & 12). MBP was used as a marker for mature differentiated oligodendrocytes. 
Day 1 or day 2 cultures from transgenic and wild-type mice were less differentiated when 
compared to day 3 or day 4 cultures, which were characterized by extensive branching and 
interconnections in oligodendrocytes. In cultures from transgenic mice, positive PSA staining 
was observed in both immature (Fig. 11A & E) and mature oligodendrocytes (Fig. 12A & E) 
with no staining in the cultures from wild-type mice (Fig. 11I, M & 12I, M). The number of 
MBP positive cells at each day of culture was counted by fluorescence microscopy. Several 
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different random fields of view were selected for counting and the percentage of MBP 
positive cells was calculated as a function of time (Fig. 13A). Analysis of the data showed no 
significant difference in the percentage between transgenic and wild-type cells, indicating no 
change or delay in the process of in vitro differentiation due to PSA overexpression. 
However, the morphology of the differentiated transgenic oligodendrocytes was 
comparatively less mature than that of wild-type cells. The transgenic oligodendrocytes were 
less branched, 33.5 ± 10.3 (mean ± SD) branches, with fewer processes and membranous 
extensions when compared to wild-type oligodendrocytes, which had 58 ± 25 (mean ± SD) 
branches (Fig. 13B). Analysis of cell soma diameter indicated no significant difference 
between the cultures from tg and wt mice. Although PSA staining in the culture from tg mice 
showed PSA localisation in the branches, membranous extensions of oligodendrocytes, there 
was also PSA staining in the perinuclear region and around the cell body [Fig. 11 (A, E) & 12 
(A, E)]. Co-staining of PSA with Golgi marker, giantin (1:200) in cultures from tg mice 
showed no co-localization in the less mature oligodendrocytes (Fig. 15A-D), whereas there 
was partial co-localization in mature (Fig. 15E-H) differentiated oligodendrocytes.  
In mature oligodendrocytes, normally, PSA-NCAM is localised in the plasma membrane, but, 
since the mature oligodendrocytes from transgenic mice showed PSA staining in the 
perinuclear region and also partial localisation of giantin and PSA, the possibility of 
mislocalisation of NCAM (carrier of PSA) or other glycoproteins like L-MAG, a marker for 
differentiated oligodendrocyte, around the perinuclear region was analysed. In order to 
analyse the above possibility, immunofluorescence double staining of PSA with NCAM (Fig. 
16A-H) and L-MAG antibodies (Fig. 14A-D) and double staining for NCAM and L-MAG 
(Fig. 17A-H) was performed. Analysis of NCAM and L-MAG stainings from the cultures of 
both transgenic and wild-type mice showed that both the proteins were normally distributed in 
the plasma membrane, membranous extensions of mature oligodendrocytes and there was no 
alteration in their distribution between cultures from transgenic and wild-type mice. Double 
staining of oligodendrocytes from transgenic mice with NCAM and PSA antibodies, showed 
co-localization of NCAM and PSA in the membranous extensions. However, in the 
perinuclear region, NCAM showed only a weak staining when compared to the strong PSA 
staining. Besides, there was no co-localisation of NCAM and PSA in the perinuclear region 
(Fig. 16E-H). Thus, these observations suggest the possibility of other proteins carrying PSA 
apart from NCAM in the mature oligodendrocytes from transgenic mice.  
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Figure 11: PSA and MBP expression in immature oligodendrocytes. Primary oligodendrocyte culture from 
tg and wt animals was co-stained for PSA (A-M) and MBP (B-N). (A-D & E-H) and (I-L & M-P) represent the 
different morphologies of tg and wt oligodendrocytes. These cultures from tg and wt mice represent immature 
oligodendrocytes. Nuclear staining was done with DAPI (C, G, K & O). (D, H, L & P) are the overlap stainings 
of PSA, MBP and DAPI. Scale bar: 50µm (A-P).  
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Figure 12: PSA and MBP expression in mature oligodendrocytes. Primary oligodendrocyte culture from tg 
and wt animals was co-stained for PSA (A-M) and MBP (B-N). (A-D & E-H) and (I-L & M-P) represent the 
different morphologies of tg and wt oligodendrocytes. PSA staining is perinuclear in the oligodendrocytes from 
tg mice. The wt oligodendrocytes are more branched and well interconnected with neighbouring 
oligodendrocytes when compared to tg oligodendrocytes, which show less extensive branching and membrane 
sheaths. Nuclear staining was done with DAPI (C, G, K & O). (D, H, L & P) are the overlap stainings of PSA, 
MBP and DAPI.  Scale bar: 50µm (A-P). 
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Figure 13: Quantification of MBP positive oligodendrocytes and branches from primary culture. Primary 
oligodendrocyte culture was prepared and the number of MBP positive oligodendrocytes was calculated and 
plotted as a function of time from wt and tg PLP-PST mice (A). Cells were counted from 3 separate culture 
preparations of tg and wt mice (n=3). Both weakly labelled immature and mature oligodendrocytes were 
included in the count. For each time point, cells were counted on 4–6 random fields of view and 400-600 cells 
were counted and documented. Nuclear staining was done with DAPI. (B) Quantification of branches from 
oligodendrocyte cultures prepared from tg and wt mice. Number of branches in MBP positive cells of day 4 
cultures from tg and wt mice were counted (n=15 cells per genotype; * P<0.05, determined by Student’s t-test). 
Branches longer than the cell soma diameter were counted for quantification. The average number of branches in 
cultures from wt mice were, 58 ± 25 branches (mean ± SD)  and in cultures from tg mice were 33.5 ± 10.3 
branches (mean ± SD). The average cell soma diameter of cultures from wt mice were, 14 ± 2 µm (mean ± SD) 
and in cultures from tg mice were, 15 ± 6 µm (mean ± SD). Quantification of branches and cell soma diameter 
was done with axiovision software from Carl Zeiss microimaging GmbH. 
 
 
Figure 14: Co-staining of oligodendrocytes from transgenic mice for PSA and L-MAG. Oligodendrocyte 
cultures from tg mice were stained for (A) PSA and (B) L-MAG. (C) Nuclear staining was done with DAPI. (D) 
Merged picture of PSA, L-MAG and DAPI staining. Scale bar: 5µm (A-D) 
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Figure 15: Immunofluorescence staining of oligodendrocytes from tg mice, for PSA and giantin. Double 
staining of primary oligodendrocyte cultures from tg mice was performed for PSA (A & E) and giantin (B & F), 
a Golgi apparatus marker. Nuclear staining was done with DAPI (C & G). (D & H) represent the merged 
stainings of DAPI, PSA and giantin. (A, B, C & D) shows an example of less differentiated oligodendrocytes 
and (E, F, G & H) shows an example of more differentiated oligodendrocytes. Scale bar: 10µm (A-H). 
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Figure 16: Co-staining of oligodendrocyte culture with NCAM and PSA antibodies. Oligodendrocyte 
cultures were prepared from wt (A-D) and tg (E-H) mice and were stained for NCAM (A & E) and PSA (B & F), 
to analyse the distribution of NCAM in the cultures from both tg and wt mice, respectively. Nuclei were stained 
with DAPI (C & G). (D & H) represent the merged pictures of NCAM, PSA and DAPI. Scale bar: 5µm (A-H). 
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Figure 17: Immunofluorescence co-staining of oligodendrocyte cultures with NCAM and L-MAG 
antibodies. (A, C, E & G) represent the culture from wt mice and (B, D, F & H) represent the culture from tg 
mice, stained for NCAM (A & B) and L-MAG (C & D). DAPI was used to stain the nuclei (E & F). (G & H) 
represent the overlap of NCAM, L-MAG and DAPI stainings. Scale bar: 5µm (A-H). 
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4.2 Analysis of PLP-CST mice 
Metachromatic leukodystrophy is a lysosomal sulfatide storage disorder caused by the 
deficiency of sulfatide degrading enzyme ASA, resulting in the accumulation of sulfatide in 
the nervous system and other organs. The manifestations of the disease include various 
neuropathological symptoms including demyelination. Till date, ASA(-/-) mice is the only 
animal model for this disease. Though ASA(-/-) mice displays similar symptoms to MLD, the 
symptoms are less severe than the patients. Moreover, these mice also do not display 
demyelination that is characteristic of the disease. Since accumulation of sulfatide is a critical 
factor for the neuropathological symptoms, including demyelination, it was hypothesized that 
an increase in sulfatide accumulation in ASA(-/-) mice would result in the display of 
symptoms akin to MLD. Hence, in order to increase sulfatide synthesis in oligodendrocytes 
and Schwann cells, transgenic mice overexpressing CST under the control of PLP promoter 
was generated and bred with ASA(-/-) mice, so that one of the offsprings from this breeding, 
tg/ASA(-/-) mice, would show an increase in sulfatide synthesis in myelinating cells. 
4.2.1 Generation of PLP-CST transgenic mice 
The transgenic construct was generated by ligating the 1.3 kb murine CST cDNA into the 
PmeI site of the PLP promoter cassette. The PLP promoter cassette consists of the 5’-flanking 
region containing the PLP promoter, first exon, first intron and the splice acceptor site of exon 
2 of the mouse PLP gene. The ATG start codon in the cassette was mutated; so that, 
translation would take place from the start codon of the cDNA construct (Fig. 18A).  
Four transgenic founder mice of the mixed C57BL/6×CBA genetic background were 
generated and identified by Southern blotting of mouse tail genomic DNA which was digested 
with StyI restriction enzyme. CST cDNA was used as a probe to identify the transgene. Two 
males with high copy number were infertile and the other two female founder mice were used 
for establishing two mice lines namely tg2645 and tg2639.  Generation of transgenic mice and 
identification of transgenic founder mice by Southern blotting was performed by Dr. Simon 
Fewou. tg2645 carried a higher copy number of the transgene when compared to tg2639. The 
two founder mice tg2645 and tg2639 were bred with ASA(-/-) mice. The offsprings from this 
breeding were of the mixed C57BL/6×CBA×129Ola genetic background and were of the 
following four genotypes - tg/ASA(-/-), tg/ASA(+/-), ASA(-/-) and ASA(+/-). Mice of all the 
four genotypes were used for further analysis. 
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4.2.2 Northern blot analysis of CST transgene expression 
Northern blot analysis of brains from 14-months-old animals, from both lines tg2645 and 
tg2639, was carried out to detect the CST transgene expression (Fig. 18B). Total RNA from 
ASA(+/-), tg/ASA(+/-), ASA(-/-) and tg/ASA(-/-) mice was isolated and transferred onto a 
Hybond N+ nylon membrane and probed with [α-32P]-dCTP labelled CST cDNA probe. The 
CST mRNA expression in the transgenic mice on an ASA(+/-) and ASA(-/-) background, 
from both lines, was several fold higher when compared to the mRNA from ASA(+/-) and 
ASA(-/-) mice. The expression level of the tg2645 line was higher when compared to the 
tg2639 line. 
 
Figure 18: PLP-CST transgenic construct and Northern blot analysis of CST transgene expression. (A)  
Schematic representation of PLP-CST transgenic construct. (B) Expression of endogenous and transgene CST 
was analysed by Northern blot analysis. Total RNA from brain of 14-months-old tg/ko-tg/ASA(-/-), ko-ASA(-/-
), tg-tg/ASA(+/-), wt-ASA(+/-) mice from both the transgenic lines, tg2645 and tg2639, was isolated and 10 
µg/lane was loaded on an agarose gel containing formaldehyde. The size of the CST mRNA (1.8 kb) is indicated 
in the figure. The transgene expression in the tg2645 line was stronger than the tg2639 line. The endogenous 
mRNA signal was weak when compared to the transgene signal. Ethidium bromide staining served for equal 
loading of the lanes. Radioactivity was visualized with a phosphorimager screen. 
4.2.3 Purification of PAPS synthetase and synthesis of [35S]-labelled PAPS  
The CST mRNA expression in the PLP-CST mice was higher when compared to the ASA(+/-
) and ASA(-/-) mice. Hence, to compare the correlation between CST mRNA expression and 
CST enzyme activity, a sulfotransferase assay was carried out. In order to carry out this assay, 
PAPS, a sulfonate donor was needed. Hence, murine PAPS synthetase, the enzyme needed to 
synthesise PAPS, cDNA was cloned into an expression vector and transformed into BL21 
competent cells by Mandy Ruf, so that these bacteria express recombinant PAPS synthetase 
enzyme, which can be isolated and purified, for synthesising radiolabelled PAPS. 
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The bacterial cells were lysed and the crude homogenate from bacteria expressing 
recombinant PAPS synthetase was purified on a nickel chelating column and the different 
eluted fractions from the column were pooled. To the pooled fraction, Tris-glycerol buffer 
was added and the mixture was concentrated with Centricon spin columns. The concentrated 
protein was resolved on an SDS-PAGE to identify the fractions containing PAPS synthetase. 
In the lane for pooled concentrated fractions, Ps1 and Ps2, a polypeptide of ~66 kDa, 
corresponding to PAPS synthetase was observed and in the lane for flow through glycerol 
fractions, Gs1 and Gs2, no protein was observed (Fig. 19A). 
The purified PAPS synthetase was used in a reaction, containing [35S]-labelled sulfate, to 
synthesize radiolabelled PAPS. The synthesized PAPS was verified by loading it on a PEI- 
TLC plate, with [35S]-labelled sulfate as control. PAPS migrates slightly higher when 
compared to radiolabelled sulfate donor as shown in figure (Fig. 19B). 
 
Figure 19: PAPS synthetase purification and [35S]-radiolabelled PAPS synthesis. (A) Purification of PAPS 
synthetase. PAPS synthetase was purified on a HiTrap Ni2+chelating column. Eluted fractions containing protein 
were pooled and Tris (pH 7)-glycerol buffer was added to it. The protein fractions were concentrated by 
centrifugation with Centricon spin column. Ps1 and Ps2 represents the pooled eluted fractions from the column 
after concentration, containing PAPS synthetase (~66 kDa ), Gs1 and Gs2 represent the flow through glycerol 
fractions after concentration. (B) TLC analysis of [35S]-radiolabelled PAPS. Radiolabelled PAPS was 
synthesized with the purified PAPS synthetase, [35S]-labelled sulfate and ATP in a reaction buffer at 37°C for 3 
hours. Purity of the synthesized PAPS was verified on a PEI-TLC plate with [35S]-labelled sodium sulfate as 
standard and 0.9M lithium chloride as developing solvent. The radioactivity was visualized on a phosphorimager 
screen. 
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4.2.4 Increase in CST enzyme activity in PLP-CST transgenic mice 
To examine whether the CST transgene overexpression leads to an increase in CST activity, 
CST activity was compared between transgenic and wild-type mice by performing a 
sulfotransferase assay. Brain homogenates from 3-weeks and 3-months-old mice from wild-
type and tg2639 line and 4-6 months old mice from wild-type and tg2645 line were analyzed. 
After completion of the reaction, the reaction mix was analysed on a HPTLC plate. [35S]-
sulfatide was visualized by exposing the HPTLC plate to a phosphorimager screen and the 
product, sulfatide, was quantified densitometrically with AIDA software (Fig. 20A). Analysis 
of the data showed an increase in CST enzyme activity by nearly 60-fold in the tg2639 line 
and to about 200-fold in the tg2645 line when compared to wild-type controls (Fig. 20B). 
 
Figure 20: CST enzyme activity assay. Brain homogenates of 3-weeks and 3-months-old wt and tg mice (line 
tg2639) and 4-6 months-old wt and tg mice (line tg2645) were used to perform a radioactive CST assay. (A) The 
product of the assay, [35S]-labelled sulfatide, was resolved on a HPTLC plate with (60:27:4) 
chloroform:methanol:water as solvent system and detected on a phosphorimager screen. The sulfatide signal 
from wild-type mice was very weak when compared to that from tg mice (~ 2 arbitrary units for wild-type 
animals). (B) HPTLC plates were scanned densitometrically to calculate the CST activity in arbitrary units. wt-
ASA(+/-), tg-tg/ASA(+/-). 
4.2.5 CST overexpression in ASA(-/-) mice leads to an increase in sulfatide accumulation 
To analyse whether CST overexpression leads to changes in the lipid compositon in the PLP-
CST mice, lipid analysis of total brain and sciatic nerve was performed. Lipids from total 
brain of 7-months (tg2639 and tg2645 line) and 17-months (tg2645 line) or 18-months 
(tg2639 line) old ASA(+/-), tg/ASA(+/-), ASA(-/-) and tg/ASA(-/-) mice (Fig. 21A & B) and 
sciatic nerve of 18-months-old (tg2639 line) ASA(-/-) and tg/ASA(-/-) (Fig. 23A) mice were 
extracted and analyzed by TLC. In order to quantify the sulfatide and GalC concentrations, 
sulfatide and GalC standards (0.5 µg, 1 µg, 2 µg, 4 µg and 8µg) were loaded along with the 
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brain lipids from 7-months and 18-months-old mice or sulfatide, GalC and cholesterol 
standards for sciatic nerve lipids from 18-months-old mice. A standard curve was generated 
and sulfatide, GalC concentration of the brain lipids or sciatic nerve lipids was calculated 
from the standard curve and then normalised to milligram wet brain weight for brain lipids or 
normalised to cholesterol in case of sciatic nerve lipids.  
Quantification of brain lipids from 7-months-old mice, showed 1.7-fold increase in sulfatide 
levels in the tg/ASA(-/-) mice when compared to ASA(-/-) mice or ASA(+/-) mice (Fig. 22A) 
and there was no significant increase in sulfatide levels in the ASA(-/-) mice when compared 
to the ASA(+/-) mice. Despite no significant reduction in the GalC levels in both tg/ASA(-/-) 
and ASA(-/-) mice (Fig. 22B), the GalC:sulfatide ratio in both tg/ASA(-/-) and ASA(-/-) was 
significantly reduced when compared to the ASA(+/-) mice (Fig. 22C). The reduction in 
GalC:sulfatide ratio in ASA(-/-) mice was in accordance to results reported previously by 
Yagoothfam et al., (2005).  
In 17-18 months old animals sulfatide accumulation increased in tg/ASA(-/-) mice (nearly 1.4 
fold more) when compared to ASA(-/-) mice (Fig. 22D). However, the relative sulfatide 
increase in 17-18 months old tg/ASA(-/-) mice, when compared to ASA(-/-) mice, was less 
than that of 7-months-old animals, possibly indicating demyelination in these mice. Though 
the GalC levels in 18-months-old tg/ASA(-/-) mice was decreased when compared to ASA(-/-
) mice the reduction was not significant (Fig. 22E) The GalC:sulfatide ratio of 17-18 months 
old tg/ASA(-/-) mice was significantly reduced when compared to ASA(-/-) mice (Fig. 22F). 
The tg/ASA(+/-) mice from both age groups showed no significant difference in the sulfatide 
level when compared with the ASA(+/-) control mice. For data analysis lipid data from 7-
months-old animals from both the lines (2 animals per line per genotype) were combined. 
The sciatic nerves from the 18-months-old tg/ASA(-/-) mice showed a significant increase 
(nearly 1.5 fold) in sulfatide level (Fig. 23B) indicating sulfatide accumulation in the 
peripheral nervous system of these mice. The GalC:sulfatide ratio was also significantly 
reduced in the the tg/ASA(-/-) mice when compared to ASA(-/-) mice (Fig. 23D) A 
significant reduction in the GalC:sulfatide ratio in brain and sciatic nerve of tg/ASA(-/-) mice 
indicates alterations in lipid metabolism due to sulfatide accumulation. 
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Figure 21: TLC representation of total brain lipids from PLP-CST mice. Total brain lipids were extracted 
and separated on HPTLC plates from wt, tg, ko and tg/ko mice. (A) 7-months and 18-months-old mice from 
tg2639 line. (B) 7-months and 17-months-old mice from tg2645 line. Alkaline hydrolysis, to remove 
phospholipids, was carried out for all the age groups except for 17-months-old mice. NFA-non-hydroxy fatty 
acid, HFA-hydroxy fatty acid, GalC-galactosylceramide. wt-ASA(+/-), tg-tg/ASA(+/-), ko-ASA(-/-), tg/ko-
tg/ASA(-/-). 
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Figure 22: Quantification of brain lipids from PLP-CST mice. Brain lipids from 7-months (tg2639 + tg2645 
lines; n = 4 per genotype) and 18-months (tg2639 line; n = 3 per genotype) old wt, tg, ko and tg/ko mice were 
run on a HPTLC plate. Total sulfatide (A & D), GalC (B & E) values were determined by scanning the HPTLC 
plates and analyzing them densitometrically. GalC:sulfatide ratio (C & F) was calculated from the densitometric 
data. For quantification, sulfatide and GalC standards (0.5 µg, 1 µg, 2 µg, 4 µg and 8µg) were loaded along with 
the brain lipids from 7-months and 18-months-old mice. A standard curve was generated and sulfatide, Galcer 
concentration of the brain lipids was calculated from the standard curve and then normalised to milligram wet 
brain weight. (* P< 0.05, ** P< 0.005 determined by Student’s t-test). wt-ASA(+/-), tg-tg/ASA(+/-), ko-ASA(-/-
), tg/ko-tg/ASA(-/-). 
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Figure 23: Analysis and quantification of lipids from sciatic nerves of PLP-CST mice. (A) Lipids were 
extracted and separated on a HPTLC plate from sciatic nerves of 18-months-old ASA(-/-) and tg/ASA(-/-) mice 
(tg2639 line). Lipids were normalized to cholesterol, for equal loading, scanned and analyzed densitometrically 
to determine sulfatide (B), GalC (C) values and GalC:sulfatide ratio (D) was calculated (n = 3 per genotype) (* 
P< 0.05, ** P< 0.005 determined by Student’s t-test). wt-ASA(+/-), tg-tg/ASA(+/-), ko-ASA(-/-), tg/ko-tg/ASA(-
/-). 
4.2.6 Behavioural abnormalities, hind limb paralysis and motor co-ordination deficits in 
older tg/ASA(-/-) mice 
The behaviour of tg/ASA(+/-) mice that were less than 6-months of age and those that were 
even older than 18-months, was not different from that of the ASA(+/-) controls. Similarly 
there was no difference in the behaviour of tg/ASA(-/-) within one year of age, when 
compared to ASA(-/-) controls. However, tg/ASA(-/-) mice older than one year showed some 
behavioural changes. These mice when suspended by their tail clasped their hind limbs and 
folded them towards their body (Fig. 24B), indicating hind limb weakness and paralysis in 
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these mice. In contrast, tg/ASA(+/-), ASA(+/-) and ASA(-/-) (Fig. 24A) mice spread their 
hind limbs apart. Moreover, older tg/ASA(-/-) mice developed a progressive hind limb 
paralysis when compared to the ASA(-/-) controls (Fig. 24C). Motor co-ordination abilities of 
tg/ASA(-/-) mice were tested by performing a rotarod analysis. The experiment was 
performed with ASA(+/-), tg/ASA(+/-), ASA(-/-), tg/ASA(-/-) mice of different age groups. 
The experiment was conducted by training the mice for three days on a rotarod and on the 
fourth day the performance was assessed by recording the number of cumulative falls/minute 
for each mouse. Analysis of the data indicated no significant difference in the performance of 
mice that were less than 11-months-old (Fig. 24D). However, older tg/ASA(-/-) mice (21-24 
months) was unable to remain on the rod and fell more often than the ASA(-/-) control mice 
(Fig. 24E). The reason for the poor performance of the tg/ASA(-/-) could be due to hind limb 
weakness and paralysis of these mice. 
 
 
Figure 24: Behavioural analysis of PLP-CST mice. Detection of hind limb weakness (B) tg/ko mouse clasped 
their hind limbs and folded them towards their body when suspended by their tail when compared to (A) ko 
mice, which stretched their hind limbs. (C) tg/ko mice when placed on a table showed hind limb weakness and 
progressive hind limb paralysis. Rotarod analysis was performed on ko, tg/ko, wt and tg animals to analyze their 
motor co-ordination behaviour by calculating the number of cumulative falls/min. Rotarod analysis of mice up to 
11-months-old, ko and tg/ko was performed at 3 rpm (D) and 21-24 months old; ko, tg/ko, wt and tg mice was 
performed at 1.3 rpm (E). In 11-months-old mice, there was no significant difference in the performance 
between tg/ko and ko mice (D). When 21-24 months old mice were compared, the performance of tg/ko mice 
was poor and the mice fell more often from the rod due to hind limb weakness and paralysis when compared to 
ko mice. There was no significant difference in the performance between the ko, tg and wt animals (E) (* 
P<0.05, determined by Student’s t-test). wt-ASA(+/-), tg-tg/ASA(+/-), ko-ASA(-/-), tg/ko-tg/ASA(-/-). 
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4.2.7 Decrease in myelin basic protein (MBP) expression in tg/ASA(-/-) mice 
The effects of increased sulfatide accumulation on myelin and astrogliosis was investigated 
by performing a Western blot analysis on the brain of ASA(+/-), tg/ASA(+/-), ASA(-/-) and  
tg/ASA(-/-) mice. Effects on myelin was investigated by analyzing different myelin proteins 
like MBP, Fyn, CNPase (Fyn and CNPase, only on older mice) and the effects on astrogliosis 
with GFAP (only on older mice), an astrocyte marker. When 7-months-old mice, were 
analyzed, there was no significant difference in the MBP level among the different genotypes 
(Fig. 25A). However, 17-18 months old, tg/ASA(-/-) mice, showed a significant reduction in 
the MBP level when compared to ASA(-/-), tg/ASA(-/-) and ASA(+/-) mice, from both the 
transgenic lines, tg2645 (Fig. 25C) and tg2639 (Fig. 25B). No alteration in MBP level was 
found in 17-18 months old ASA(-/-) mice when compared to wild-type mice. This 
observation is in accordance with the result obtained previously (Yaghootfam et al., 2005). 
Thus, a decrease in MBP level in the older tg/ASA(-/-) mice correlates well with 
demyelination in these mice (Fig. 25B & C). No significant difference was observed in the 
protein expression level of Fyn, CNPase and GFAP among the four genotypes. 
 
Figure 25: Western blot analysis of brain from PLP-CST mice. 50 µg protein from total brain homogenate 
was loaded on an SDS-PAGE to analyze the expression of different proteins by Western blotting. (A) Analysis 
of MBP expression in 7-months-old wt, tg, ko and tg/ko mice. (B) Analysis of MBP, Fyn, CNPase, and GFAP in 
17-months-old mice from tg2639 line (n=3) and (C) MBP expression in 18-months-old mice from tg2645 line 
(n=1). β-actin served to control protein loading. wt-ASA(+/-), tg-tg/ASA(+/-), ko-ASA(-/-), tg/ko-tg/ASA(-/-). 
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4.2.8 Decrease in nerve conduction velocity in tg/ASA(-/-) mice 
Electrophysiological analysis was performed by Dr. Carsten Wessig (University of Würzburg) 
in sciatic nerves of 21-24 months old PLP-CST mice. tg/ASA(-/-) mice showed a significant 
decrease in nerve conduction velocity when compared to ASA(-/-) mice. There was no 
difference in the electrophysiological recordings between the tg/ASA(+/-) and ASA(+/-) 
mice. Moreover, the F-wave latency (the total time taken for the conduction of a signal, from 
the region of stimulus in a skeletal muscle to the dorsal root ganglion and back from the 
dorsal root ganglion to the region of stimulus) was significantly increased in tg/ASA(-/-) mice 
when compared to ASA(-/-) controls. The compound muscle action potential (CMAP) 
amplitude in tg/ASA(-/-) mice was significantly reduced (Table 11). The tg/ASA(-/-) mice 
also showed spontaneous muscle activity in the foot muscles as recorded by 
electromyography, indicating axonal degeneration in tg/ASA(-/-) mice. No spontaneous 
activity could be detected in the controls. 
Analysis of nerve conduction in sciatic nerve 
Table 11 
Genotype ASA(+/-) tg/ASA(+/-) ASA(-/-) tg/ASA(-/-) 
Age (months) 23 ± 1a 
(n = 3) 
22 ± 0 
(n = 3) 
24 ± 0 
(n  = 3) 
23 ± 1 
(n = 5) 
NCV (m/s) 42.9 ± 0.5 48.0 ± 0.1 46.6 ± 1.1 28.2 ± 6.4b 
F-wave latency (ms) 4.7 ± 0.1 5.0 ± 0.3 5.7 ± 0.5b 7.6 ± 1.3b 
CMAP amplitude (mV) 10.9 ± 4.7 16.1 ± 4.0 6.9 ± 3.5 6.3 ± 4.3 
Spontaneous activity 0/3c 0/3 0/3 5/5 
 
amean ± SD 
bdifference to ASA(+/-) is statistically significant (t-test, p<0.05) 
cnumber of mice showing spontaneous activity/number of mice examined 
4.2.9 Axonal degeneration and demyelination in the nervous system of tg/ASA(-/-) mice 
To understand the effects of increased sulfatide storage on myelin, electron microscopic 
studies were performed by Prof. Lüllmann-Rauch (University of Kiel), in the brain, spinal 
cord and N. phrenicus (peripheral nerve) of 17-18 months old tg/ASA(-/-), ASA(-/-), 
tg/ASA(+/-) and ASA(+/-) mice. The analysis indicated axonal degeneration, uncompacted 
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thin myelin formation and demyelination in central and peripheral nervous system in 
tg/ASA(-/-) mice (Fig. 26D and Fig. 27D & H) when compared to ASA(-/-) mice (Fig. 26C 
and Fig. 27C & G). Alteration or deformation in the myelin structure was not observed in the 
tg/ASA(+/-) mice (Fig. 26B and Fig. 27B & F) when compared to ASA(+/-) mice (Fig. 26A 
and Fig. 27A & E). Altogether, the electron microscopic data indicates demyelination in 
tg/ASA(-/-) mice in central and peripheral nervous system when compared to ASA(-/-) mice. 
 
 
Figure 26: Electron microscopic analysis of corpus callosum from PLP-CST mice. Electron microscopy was 
performed on corpus callosum of (A) ASA(+/-), (B) tg/ASA(+/-), (C) ASA(-/-), (D) tg/ASA(-/-) mice. The 
tg/ASA(-/-) electron microscopic picture show several axons with reduced myelin thickness, an indication of 
demyelination in these mice. (Pictures for electron microscopy were taken by Prof. Lüllmann-Rauch). 
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Figure 27: Electron microscopic analysis of N.phrenicus from PLP-CST mice. Electron microscopy was 
performed on N. phrenicus (peripheral nerves). (A-D) are lower magnification (50µm) pictures and (E-H) are 
higher magnification (5µm) pictures of the nerve. (A & E)-ASA(+/-), (B & F)-tg/ASA(+/-), (C & G)-ASA(-/-) 
and (D & H)-tg/ASA(-/-) mice. (Pictures for electron microscopy were taken by Prof. Lüllmann-Rauch). Scale 
bars: 50 µm (A-D) and 5 µm (E-H). 
4.2.10 Effects of sulfatide accumulation on elongation and initiation factors and TGF-β 
III receptor 
Mutations in elongation factors lead to hypomyelination disorders like vanishing white matter 
disease (van der Knapp et al., 2002). Hence, in order to investigate whether demyelination 
due to sulfatide accumulation in tg/ASA(-/-) mice, alters expression of elongation factors and 
other genes like TGF-β III receptor, a semi quantitative RT-PCR was done on ASA(+/-), 
tg/ASA(+/-), ASA(-/-) and tg/ASA(-/-) mice. Total RNA was isolated from brain and cDNA 
was synthesized by performing a reverse transcription reaction on the isolated total RNA. 
This cDNA was then used for carrying out PCR reactions as described for different elongation 
factors, initiation factors (eEF2, eIF2, eIF4A2, eIF4b) (Fig. 28A) and TGF-β III receptor (Fig. 
28B). β-actin was used for normalizing the mRNA expression level. Analysis of the data 
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indicated that there was no alteration in the mRNA expression level of elongation factors, 
initiation factors and TGF-β III receptor. 
 
 
Figure 28: mRNA expression of elongation factors, initiation factors and TGF-β III receptor in PLP-CST 
mice brain. Brain mRNA was extracted from 17-months-old wt, tg, ko and tg/ko mice. RT-PCR analysis was 
performed, after reverse transcription, with specific primers. (A) mRNA expression of different elongation and 
initiation factors (eEF2, eIF2, eIF4A2, eIF4b) and β-actin as normalisation control for mRNA expression of 
elongation and initiation factors. (B) RT-PCR analysis of TGF-β III receptor with β-actin as normalisation 
control. M-DNA marker, λ phage DNA cut with HindIII/EcoRI restriction enzymes. wt-ASA(+/-), tg-tg/ASA(+/-
), ko-ASA(-/-), tg/ko-tg/ASA(-/-). 
4.2.11 Analysis of axonal nodes and paranodes in tg/ASA(-/-) mice 
Electron microscopic analysis of tg/ASA(-/-) mice indicated demyelination and irregular 
ensheathment of myelin around axons. Electrophysiological studies showed a decrease in the 
nerve conduction velocity in these mice. Reports from CST knock-out mice indicated that 
sulfatide is necessary for maintenance of ion channels and formation of paranodal junctions 
and lack of sulfatide results in redistribution of sodium and potassium channels (Honke et al., 
2002; Ishibashi et al., 2002). Hence, in order to investigate the effects of sulfatide 
accumulation on the nodal and paranodal regions of the axonal membrane, teased fibres of 
sciatic nerves from ASA(+/-), tg/ASA(+/-), ASA(-/-) and tg/ASA(-/-) were prepared and 
immunofluorescence staining of paranodin, a paranodal marker (Fig. 29A, D, G & J) and Na+ 
channel, a nodal marker (Fig. 29B, E, H & K) was carried out and analysed by fluorescence 
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microscopy (Fig. 29A-L). Observations of nodes and paranodes indicated no significant 
alteration in the distribution of Na+ channel and paranodin in the tg/ASA(-/-) mice when 
compared to the controls. Analysis of paranodin stainings indicated a diffuse staining pattern 
in some regions of the sections, which was, however also observed in the controls. 
 
Figure 29: Sodium channel and paranodin stainings of sciatic nerve from PLP-CST mice. The nodal and 
paranodal regions of the axonal membrane of PLP-CST mice were stained for paranodin (A, D, G & J) and 
sodium channel (B, E, H & K), respectively. Stainings were done on wt (A, B & C), tg (D, E & F), ko (G, H & I) 
and tg/ko (J, K & L) mice. (C, F, I & L) represent the merged pictures. wt-ASA(+/-), tg-tg/ASA(+/-), ko-ASA(-/-
), tg/ko-tg/ASA(-/-). Scale bar: 5µm (A-L).  
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5. Discussion 
5.1 Role of PSA-NCAM in oligodendrocyte differentiation and myelination 
Myelin membrane is an electrically insulating layer that ensheath the axons. Myelin is 
synthesized by oligodendrocytes in the CNS and Schwann cells in the PNS, respectively. The 
formation and maintenance of myelin membrane involves biosynthesis and degradation of 
various lipids, proteins and carbohydrates. De-regulation in the expression of genes involved 
in these regulatory mechanisms results in changes in myelin formation, structure, maintenance 
and stability leading to different pathological conditions like demyelination. Proliferation, 
migration and differentiation of oligodendrocytes are an integral part of myelin biogenesis. 
Oligodendrocyte maturation and onset of myelination in the central nervous system is 
regulated by several positive regulators like electrical activity in axons (Barres and Raff, 
1993) and cell adhesion molecules and negative regulators like sulfatide (Bansal et al., 1999) 
and PSA (Charles et al., 2000). Some of these signals are expressed during proliferation and 
migration and downregulated during maturation of oligodendrocytes. PSA-NCAM is one such 
negative regulator which is expressed in migratory oligodendrocyte progenitor cells (Wang et 
al., 1994), whose expression facilitates the cells to respond to external signals spatially and 
temporally (Rutishauser and Landmesser, 1996).  
PSA-NCAM expression is downregulated when oligodendrocytes undergo differentiation to 
become myelin forming mature oligodendrocytes (Trotter et al., 1989; Bartsch et al., 1990). 
Downregulation of PSA in oligodendrocytes is proposed to be due to downregulation of PST 
in oligodendrocytes (Stoykova et al., 2001). Although PSA downregulation plays a role 
during myelination, the answer to the question whether PSA downregulation is important for 
oligodendrocyte differentiation and myelination was not clear. Hence, in order to address this 
question, in this study, transgenic mice overexpressing PST under the control of PLP 
promoter was generated and analyzed. 
Expression of PLP gene is upregulated in differentiated oligodendrocytes. Hence, by 
expressing PST under the control of PLP promoter, the downregulation of PST is prevented in 
adult animals and the NCAM-120 in differentiated oligodendrocytes of transgenic mice 
remain polysialylated. Analysis of transgenic mice indicated an upregulation in transgene 
expression in postnatal day 1 and 7-week-old animals, with a reduction in the endogenous 
mRNA (Fig. 4B) in accordance with published results of PST expression in adult mouse brain 
(Ong et al., 1998). Overexpression of PST led to PSA expression in the white matter regions 
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of the brain (Fig. 5A). Immunofluorescence stainings of PSA and MBP showed a partial co-
localisation of PSA and MBP in oligodendrocytes clearly indicating localization of PSA in 
myelin (Fig. 6A & B).  
Analysis of myelin showed loss of myelin in transgenic mice, which was evident from the 
reduction in myelin weight in 12-week-old transgenic animals. Despite myelin loss, there 
were, however, no behavioural deficits observed in the transgenic mice. Structural 
abnormalities in the transgenic mice, as revealed by electron microscopy, like axonal 
degeneration, redundant myelination and hypomyelination indicate that myelin formation is 
affected in these mice (Fewou et al., 2007). Although there was myelin loss and structural 
abnormalities in myelin, myelin formation did occur in the transgenic mice. This in a way 
shows that PSA downregulation is not necessarily required for myelin formation. Unstable 
myelin in the transgenic mice suggests a possible role of PSA in maintenance and 
stabilization of myelin. 
Apart from NCAM several gangliosides are also oligosialylated and gangliosides like GM1 
are one of the important components of the myelin membrane. Data from Sheikh et al., (1999) 
suggest that mice lacking sialylated gangliosides also display axonal degeneration and myelin 
related abnormalities. Hence, the likelihood of alterations in brain gangliosides in transgenic 
mice was analyzed, which however indicated no major difference in ganglioside composition 
between the transgenic and wild-type mice (Fig. 10). Thus, the observations above indicate 
that most of the effects on myelin due to PST overexpression are a result of polysialylation of 
NCAM in oligodendrocytes.  
In vitro oligodendrocyte cultures from transgenic mice showed no significant difference in 
differentiation except that there was lower number of branches in oligodendrocyte cultures 
from transgenic mice when compared to that from wild-type mice (Fig 13A & B). PSA 
staining in oligodendrocytes from transgenic mice was not only found in the branches and 
membrane extensions of oligodendrocytes, but was also concentrated around the cell body 
(Fig. 11 & 12). Such perinuclear localization of PSA was also reported by Franceschini et al., 
(2004) and Lavdas et al., (2006) who overexpressed PSA by transducing neural precursors or 
Schwann cells with retroviral vectors encoding PST or STX, respectively.  
Extension of cellular processes during oligodendrocyte differentiation is essential for 
myelination. During the process of oligodendrocyte differentiation, cytoskeletal 
rearrangement occurs in these cells, characterized by an extended branched morphology in 
differentiated oligodendrocytes. Data from Klein et al., (2002) showed that interaction of Fyn 
kinase with cytoskeletal protein Tau promotes process outgrowth of oligodendrocytes. Tau is 
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a microtubule associated protein that has been shown to induce microtubule assembly and 
bundle formation leading to process formation in oligodendrocytes (Brandt, 1996). Published 
reports show compartmentalization of NCAM-120 and Fyn kinase in the lipid rafts of 
oligodendrocytes (Kramer et al., 1999). Hence, it is quite likely that in oligodendrocyte 
cultures from transgenic mice due to overexpression of PST, the interaction between PSA-
NCAM and Fyn kinase is affected causing interference in the Fyn-Tau-microtubule 
interactions, resulting in a lower number of branches in these oligodendrocytes. Further 
experiments need to be performed to verify this hypothesis. 
PSA-NCAM is synthesized in the trans-Golgi network and transported via vesicles to the 
membrane. In the cultures from transgenic oligodendrocytes, NCAM co-localized with PSA 
in the membrane extensions but not in the perinuclear region (Fig. 16). Moreover, the overall 
distribution of NCAM or other glycosylated proteins like MAG were not altered in these 
cultures (Fig. 14, 16 & 17). Since, the distribution and expression of NCAM was not altered, 
it is quite likely that other proteins apart from NCAM could carry PSA. Published reports 
show that PST is autopolysialylated both in vivo and in vitro. In vitro studies with COS-1 
cells show that autopolysialylated PST localises to the Golgi apparatus and cell surface of 
these cells (Mühlenhoff et al., 1996; Close et al., 1998). Although autopolysialylation of PST 
is not required for NCAM polysialylation, it does enhance NCAM polysialylation (Close et 
al., 2001). Since PST is overexpressed in the transgenic mice, the possibility of 
autopolysialylation of PST in these transgenic oligodendrocytes is quite likely. This 
autopolysialylated PST might localize around the Golgi apparatus and the perinuclear region 
as observed in the transgenic oligodendrocytes. 
Increase in PSA expression on NCAM-120 led to a decrease in the number of differentiated 
oligodendrocytes in the corpus callosum of PLP-PST mice. This was evident from the in situ 
hybridisation analysis of 1-week-old mouse brains for mature oligodendrocyte markers like 
PLP (Fewou, 2005), MBP and MAG (Fig. 8). Although PLP is a marker for mature 
oligodendrocytes a subset of OPCs also express an isoform of PLP, namely DM-20 (Spassky 
et al., 1998). Hence, the decrease in differentiated PLP positive cells could actually be a 
decrease in this subset of OPCs. But, analysis of other markers of mature oligodendrocytes, 
other than PLP, like MBP and MAG, also showed a reduction in the number of 
oligodendrocytes expressing these markers in the corpus callosum of 1-week-old PST 
transgenic mice. This in a way indicates a decrease in the number of differentiated 
oligodendrocytes in the 1-week-old PLP-PST transgenic mice. However, analysis of 4-week-
old mice did not show a significant decrease in PLP expressing cells (Fewou, 2005). 
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Altogether, these results indicate the possibility of a delay in differentiation of 
oligodendrocytes in 1-week-old mice, which at later time points is compensated by an 
increase in the differentiation process to reach normal values.  
Presence of PSA on NCAM is known to decrease NCAM mediated membrane-membrane 
interactions (Rutishauser, 1998). Moreover, removal of PSA can enhance the interactions 
between NCAM and NCAM or NCAM and other cell adhesion molecules like L1, NgCAM, 
cadherins and receptors like FGF receptors. PSA in general is believed to cause steric 
inhibition of membrane-membrane apposition causing a decrease in cell adhesion 
(Rutishauser and Landmesser, 1996) by either preventing interaction of NCAM on two 
adjacent cells or the same cell or by NCAM-independent interactions (Fujimoto et al., 2001). 
This in a way could influence the membrane-membrane adhesion and change the intercellular 
space upon removal of PSA-NCAM or influence clustering of NCAM.  
The exact role of PSA-NCAM in myelination is still not clear. The persistence of PSA 
expression in oligodendrocytes could interfere with NCAM interactions within the 
oligodendrocytes as well as between oligodendrocytes and neurons. Moreover, as mentioned 
above, the interaction of NCAM and other adhesion molecules and receptors could also be 
altered. NCAM along with cadherins and other members of the immunoglobulin superfamily 
like L1 and MAG play a role in axon-glia interactions (Doyle and Colman, 1993; Payne et al., 
1996). PSA-NCAM on axons acts as a negative regulator of myelination (Charles et al., 
2000). Since axon-oligodendrocyte interaction is critical for myelination, PSA overexpression 
in oligodendrocytes could lead to disruption of homophilic NCAM-NCAM or heterophilic 
NCAM-cell adhesion molecules interactions between oligodendrocytes and axons. This could 
have an impact in the adhesion and ensheathment of myelin sheath around axons, despite the 
formation of myelin sheath, leading to improper myelin compaction and myelin instability as 
observed in the transgenic mice. 
The involvement of PSA in signal transduction cascades, besides modulating 
homophilic/heterophilic interactions has been recently reported. Role of PSA in brain derived 
neurotrophic factor (BDNF) signalling cascade in cortical neuron differentiation (Vutskis et 
al., 2001) and in long term potentiation (Muller et al., 2000) has been reported. Seidenfaden et 
al., (2003) reported that EndoN removal of PSA from NCAM activates the MAP kinase 
pathway in neuroblastoma and rhabdomyosarcoma cell lines. The exact mechanism as to how 
PSA is involved in oligodendrocyte differentiation and myelination is far from clear. 
Although an anti-adhesive property of PSA on NCAM is one explanation, the other 
possibility could be due to alterations in signaling cascades. Kramer et al., (1999) showed that 
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NCAM-120 is compartmentalized in the same subdomain of lipid rafts as Fyn kinase in 
oligodendrocytes and the possibility of NCAM interacting with Fyn could lead to activation 
of the src, non receptor tyrosine kinase, pathway. Published data show that activation of Fyn 
kinase is required for oligodendrocyte differentiation (Osterhout et al., 1999; Klein et al., 
2002). Hence, the possibility of interaction of NCAM with Fyn kinase needs to be studied 
further to substantiate this hypothesis. A detailed analysis of the interaction partners and 
signaling cascades involved in myelination would definitely shed more light on the 
mechanisms of how PSA-NCAM mediates oligodendrocyte differentiation and myelination. 
Altogether, it is clear from the above results that PSA downregulation is important but not a 
prerequisite for oligodendrocyte differentiation and myelin formation and its presence in 
myelin interferes with myelin maintenance and stability. 
Published results suggest that PSA-NCAM facilitates oligodendrocyte migration (Decker et 
al., 2000; Franceschini et al., 2004). Since, oligodendrocyte migration is a key step in the 
process of myelination, it will be interesting to observe whether overexpression of PST 
increases the migratory potential of oligodendrocytes. 
PST expression is not limited to oligodendrocytes of CNS but is also prominently expressed 
in Schwann cells of PNS. Analysis of changes in peripheral nervous system myelin and 
Schwann cell migration, differentiation and myelination will enable to better understand the 
function and regulation of PSA-NCAM in CNS and PNS respectively. 
5.2 Effect of increased sulfatide accumulation in ASA(-/-) mice and its 
significance to MLD 
The differentiation of oligodendrocytes to mature myelin forming cells involves synthesis of 
variety of lipids and proteins. The myelin membrane is composed of 70% lipids and 30% 
proteins (Baumann and Pham-Dinh, 2001). Of the different lipids, glycosphingolipids like 
sulfatide and GalC play a crucial role in myelin formation, maintenance and stability (Bosio et 
al., 1996; Coetzee et al., 1996; Honke et al., 2002). De-regulation in the degradation pathways 
of these lipids can lead to severe myelin associated disorders like MLD (von Figura et al., 
2001). 
Sulfatide storage is a critical step for the disease manifestation in humans. ASA(-/-) mice 
show only 1.4-fold increase in sulfatide at 2 years of age (Saravanan et al., 2004) when 
compared to late infantile MLD patients where sulfatide levels are increased 3 to 4-fold 
(Kolodny, 1995). In adult MLD patients, there is only less than 2-fold increase in sulfatide 
(von Figura et al., 2001), possibly due to residual ASA activity in these patients. Hence, 
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ASA(-/-) mice exhibit sulfatide storage that is less than that in infantile MLD, which could 
probably be contributing to the lack of demyelination in the older mice. Therefore, an animal 
model that exhibits increased sulfatide storage and the characteristic symptoms of the patients 
including demyelination can enable us to better understand and elucidate the molecular 
mechanisms and treatment options of the disease. Therefore, to increase sulfatide storage, an 
improved mouse model was generated by overexpressing cerebroside sulfotransferase (CST) 
gene under the control of the PLP promoter in ASA(-/-) mice, so that these mice [tg/ASA(-/-)] 
accumulate an increased amount of sulfatide in oligodendrocytes. 
Analysis of transgenic mice revealed an increase in transgene expression in the brain of 
tg/ASA(-/-) mice (Fig. 18B). CST assay showed a substantial increase in CST activity in the 
transgenic mice when compared to wild-type controls (Fig. 20). Comparison of CST activity 
between tg mice at 3-weeks and 3-6 months of age showed that at 3-weeks, CST activity is 
higher when compared to 3-6 months of age. The activity of PLP promoter in mice reaches its 
peak at around 3-weeks postnatal; consequently, PLP mRNA expression also reaches a 
maximum at around 3-weeks. On the other hand the expression of CST mRNA is maximum 
at postnatal day-14, followed by a decrease in its expression at later time points (Yaghootfam 
et al., 2005). Hence, the higher CST activity of tg mice at 3-weeks is due to the maximum 
PLP promoter activity at this time point when compared to tg animals at 3-6 months of age, at 
which time point the PLP promoter activity is decreased.  
Lipid analysis of tg/ASA(-/-) mice showed a 1.7 to 2-fold increase in sulfatide level in 7- 
months and 1.4-fold increase in 18-months-old mice brain when compared to ASA(-/-) mice 
(Fig. 22).  Lipid analysis of sciatic nerve from 18-month-old tg/ASA(-/-) animals showed a 
1.5-fold increase in sulfatide level when compared to ASA(-/-) mice (Fig. 23). Although the 
concentration of sulfatide in the tg/ASA(-/-) mice increased with age (7-months - ~10µg/mg 
wet weight when compared to 18-months - ~25µg/mg wet weight), there was a reduction in 
the relative net sulfatide accumulation between the tg/ASA(-/-) and ASA(-/-) mice of 7-
months and 18-months (from 2-fold to 1.4-fold). The reason for this reduction could be due to 
the demyelination in older animals resulting in a loss of myelin membrane. However, it was 
interesting to observe that the tg/ASA(+/-) mice did not show a significant increase in 
sulfatide level when compared to wt/ASA(+/-) mice, despite the nearly 60 to 200-fold 
increase in CST activity. This shows that CST activity may not be the limiting factor for 
sulfatide synthesis. Moreover, this also in a way highlights the complex biochemical 
mechanisms regulating lipid synthesis. One reason for a no increase in sulfatide level in 
tg/ASA(+/-) mice can be that there is an increase in the turnover of sulfatide in tg/ASA(+/-) 
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mice. Reports from Burkart et al., (1981) show that during the active period of myelination in 
mice, a pool from the synthesized sulfatide is transported via vesicles to the lysosomes and 
rapidly degraded in the lysosomes before getting incorporated into the myelin membrane. 
Normally sulfatide is transported from the Golgi apparatus to the myelin membrane via 
vesicles and from the myelin membrane sulfatide is endocytosed and then transported to 
lysosomes for the degradation of sulfatide. Hence, it is possible that in the tg/ASA(+/-) mice, 
sulfatide from the synthesized pool is transported directly to the lysosomes for degradation 
thereby increasing the turnover of sulfatide. The alternate explanation can be that there is a 
decrease in ceramide synthesis leading to the decreased GalC synthesis, so that, GalC 
becomes the limiting factor. One cannot also rule out the possibility of a reduction in sulfate 
donor PAPS, so that there is inefficient transfer of sulfonate group to GalC, leading to 
decreased sulfatide accumulation than expected. This scenario is also true for CGT transgenic 
mice which showed only a marginal increase in GalC and a reduction in sulfatide level despite 
signficant increase in CGT activity (Fewou et al., 2005). 
In MLD patients, along with the increase in sulfatide accumulation, a decrease in GalC level 
has been observed, indicating the metabolic alterations as a result of sulfatide accumulation. 
Since both GalC and sulfatide levels are altered in patients, the most sensitive indicator for 
alterations in lipid metabolism is not the absolute amount of sulfatide stored, but the ratio of 
GalC:sulfatide (von Figura, 2001). GalC:sulfatide ratio in humans decreases from 4 in normal 
white matter to 0.5 in MLD patients (Norton and Poduslo, 1982). In accordance to that 
reported for patients, the GalC:sulfatide ratio in tg/ASA(-/-) mice was also significantly 
reduced in both younger and older animals to nearly 1 and 0.5 respectively (Fig. 22). The 
exact reason for this decrease in GalC level is still not clear. The possible explanation can be 
that, as a result of sulfatide accumulation, the GalC synthesis is somehow inhibited. Thus, it is 
clear that the tg/ASA(-/-) mice accumulate sulfatide to significantly higher levels in both 
central and peripheral nervous system compared to ASA(-/-) mice and show a reduction in 
GalC:sulfatide ratio, a key indicator of the disease. 
The main clinical manifestations of MLD patients include ataxia, tremors, dementia, postural 
abnormalities and progressive spastic quadriparesis (weakening of all four limbs). Increased 
sulfatide storage in older tg/ASA(-/-) mice resulted in behavioural abnormalities like motor 
co-ordination deficits, progressive hind-limb weakness, decreased nerve conduction velocity 
and paralysis akin to MLD patients which is in contrast to the mild behavioural phenotypes 
observed in 2-year-old ASA(-/-) mice (Fig. 24). Electrophysiological studies also showed a 
decreased muscle action potential and spontaneous muscle activity, which could indicate 
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axonal degeneration and muscle denervation in the peripheral nervous system (Table 11). It 
still remains to be verified whether tg/ASA(-/-) mice also display any forms of memory 
deficits like MLD patients. Though the tg/ASA(-/-) mice undergo progressive demyelination, 
the average life span of these mice when compared to ASA(-/-) mice was not significantly 
different.  
Electron microscopic analysis of tg/ASA(-/-) mice indicated demyelination, axonal 
degeneration and uncompacted myelin in both central and peripheral nerves (Fig. 26 & 27). 
Many storage granules containing sulfatide were also observed, resembling the metachromatic 
granules seen in MLD patients. These storage materials could be phagocytic macrophages 
engulfing the degenerated myelin. Regions of uncompacted and thin myelin sheaths are 
indications for demyelination and remyelination in these mice. From the analysis of the 
neuropathological symptoms, the behavioural deficits in tg/ASA(-/-) mice could be attributed 
to demyelination in central and peripheral nervous system, as a result of sulfatide storage.  
Comparison of MBP protein levels in 7-months-old tg/ASA(-/-) and ASA(-/-) mice showed 
no difference in the protein expression. However, MBP protein expression was reduced in 17-
18 month old tg/ASA(-/-) animals when compared to ASA(-/-) mice. The reduction in MBP 
levels in 17-18 months old mice suggests demyelination in these mice. As there was no 
change in the GFAP expression level, astrogliosis could not be detected at least at the 
biochemical level in the tg/ASA(-/-) mice (Fig. 25).  
The ultimate goal of an animal model for MLD is to understand the molecular mechanisms of 
the disease and explore the therapeutic options for MLD. Therapeutic interventions have been 
tried successfully for lysosomal storage diseases like e.g. Fabry disease, Tay-Sachs disease 
and Krabbe’s disease (Gieselmann et al., 2003). Till date, though therapies like bone marrow 
stem cell based gene therapy (Matzner et al., 2000; Matzner et al., 2002) and enzyme 
replacement therapy (Matzner et al., 2005) have been proposed and tested on ASA(-/-) mice 
as a possible cure for MLD, due to lack of demyelination in the nervous system of these mice, 
the significance of ASA(-/-) mouse model for therapy related research is still debatable. The 
main setback in the treatment of MLD is the inability of ASA to effectively cross the blood 
brain barrier of the CNS. Enzyme replacement therapy in ASA(-/-) mice led to a major 
reduction in sulfatide only in peripheral nerves and to a small extent in CNS. The reduction in 
CNS is mainly due to sulfatide clearance from phagocytes representing activated microglial 
cells rather than from neurons or oligodendroglia (Matzner et al., 2005). Hence, 
demyelination in MLD per se may not be effectively treated with enzyme replacement 
therapy. In contrast to ASA(-/-) mice, tg/ASA(-/-) mice display progressive demyelination in 
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both CNS and PNS. Electron microscopy revealed hypertrophic neuropathy, axons 
surrounded by Schwann cells without myelin, and axons surrounded by uncompacted myelin 
in the peripheral nervous system. These observations indicate that tg/ASA(-/-) mice have the 
capacity to remyelinate demyelinated axons. Though the problems associated with gene 
therapy or enzyme replacement therapy (ERT) are still valid, hints of remyelination in 
tg/ASA(-/-) mice, opens some new possibilities for treatment. 
The possible signs of demyelination and remyelination in tg/ASA(-/-) mice open the 
possibility of analyzing the expression of PSA-NCAM in these mice. Reports from multiple 
sclerosis patients suggest that PSA-NCAM expression is an inhibitor of remyelination in the 
patients (Charles et al., 2002). Hence, from an academic and therapeutic point of view, it is 
interesting to analyse whether PSA-NCAM is re-expressed in demyelinated axons of 
tg/ASA(-/-) mice and if so whether removal of PSA-NCAM facilitates remyelination in these 
mice. 
Although tg/ASA(-/-) mice show increased accumulation of sulfatide and demyelination, one 
cannot neglect the fact that CST transgene is overexpressed leading to 60 to 200-fold higher 
CST activity in these mice. It cannot be ruled out completely that such an increase in 
transgene expression could induce stress in the cells of these animals, thereby inducing the 
expression of stress induced proteins like heat shock proteins or cytokines like TNF-α. 
In many of the lysosomal storage disorders, the connection between lipid metabolism and 
demyelination is far from clear, especially in MLD, where sulfatide accumulation leads to 
progressive demyelination. Sulfatide storage is not just limited to the lysosomes but also to 
the lipid rafts in the plasma membrane, particularly myelin (Eto et al., 1976; Malone et al., 
1966; Poduslo et al., 1982). Sulfatide plays an important role in signal transduction cascades, 
myelin formation, maintenance and function. Hence, sulfatide increase, as in MLD, can alter 
the raft stoichiometry and distribution of raft associated lipids and proteins. Recent reports 
suggest that sulfatide storage leads to a negative regulation of myelin and lymphocyte (MAL) 
protein synthesis (Saravanan et al., 2004), demonstrating a link between the regulatory 
mechanisms of lipid and protein synthesis. MAL is a myelin proteolipid protein that binds to 
glycosphingolipids, particularly sulfatide. Both sulfatide and MAL are part of lipid rafts in 
myelin. Analysis of tg/ASA(-/-) show a decrease in MBP level. This decrease could be due to 
demyelination observed in these mice. Hence, it will be more interesting to analyse the 
expression of MAL protein in the tg/ASA(-/-) mice, because MAL has been shown to be 
required for proper maintenance of myelin and stability of axon-glia interactions (Schaeren-
Wiemers et al., 2004). Altogether, it is possible that transport of MAL to lipid rafts of myelin 
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membrane is interfered due to increase in sulfatide accumulation and disrupts the myelin 
stability.  
Reports from Brown et al., (1993) show that sulfatide and proteolipid protein (PLP) are co-
transported in vesicles to the myelin membrane. The fact that both sulfatide and PLP are 
transported in very close association highlights the significance of this lipid-protein 
interactions. PLP is a myelin protein that plays an important role in stabilizing membrane 
junctions after compaction. Hence, it is quite possible that any changes in the metabolism of 
sulfatide could affect the metabolism of PLP, thereby affecting myelin stability and 
compaction. 
In conclusion, tg/ASA(-/-) mice is the first improved mouse model of MLD with increased 
sulfatide storage, leading to progressive demyelination both in CNS and PNS and exhibiting 
the neuropathological symptoms like hindlimb weakness, paralysis, slow nerve conduction 
velocity and hypertrophic peripheral neuropathy similar to human MLD patients. Further 
analysis of these mice would enable to better understand and resolve the molecular 
mechanisms of the disease, besides, exploring the therapeutic options for MLD patients with 
this mouse as a model system. 
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